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A novel cell culture system was designed to serve as a model of 
neuroinflammation. Neurons, astrocytes, and microglia derived from embryonic and 
perinatal rat cortical tissue were combined in a three-dimensional hydrogel utilizing a 
method that facilitated cell maturation and viability. Chemical challenge of the cultures 
with a broad pro-inflammatory stimulus resulted in the production of inflammatory 
cytokines and other associated molecules commensurate with the response observed in 
vivo and in other in vitro systems. It was hypothesized that mechanical deformation of the 
multitypic neural cell cultures would produce a similar response and thus validate the 
system as an in vitro model of traumatic brain injury-induced neuroinflammation. 
Mechanical injury delivered using custom-manufactured culture chambers and injury 
devices successfully imparted a moderate level of cell death to the cultures. It was 
determined that a mechanically-induced inflammatory response required chemical 
stimulation prior to the injury. The research presented here describes the generation and 
characterization of a novel in vitro culture system and its implementation in experiments 
designed to model secondary injury mechanisms associated with injury-induced 
neuroinflammation. The findings of these studies, applications of the culture system, and 









 Traumatic brain injury (TBI) is a major public health concern due to its incidence 
(1.7 million cases in the U.S. annually [1]) and lack of treatment options. Despite the 
development of promising therapies using animal models, none have translated 
successfully into clinical trials [2, 3]. The difficulty likely stems from the complexity of 
the response to an injury with causes that are highly variable. Numerous biochemical 
processes are triggered in response to TBI. The signaling cascades associated with 
inflammation are integral components of the secondary injury mechanisms that result in 
long-term deficits post-injury. Many of these cascades are initiated through microglial 
activation, which can be induced through post-injury death of, or cytokine release by 
other cell types, and propagated by the same mechanisms as well as by signaling from 
other microglia [4]. The activation of members of the family of purinergic receptors 
appears to play a key role in the response of microglia to injury.  
Although in vivo models have the inherent advantage of using an intact animal in 
which the all of the systems involved in the injury response are present, they lack the 
controllability of cell culture models. In vitro tissue models provide a highly tunable 
environment in which in vivo-like phenomena can be simulated in a controlled, 
reproducible fashion. Further, three-dimensional (3-D) cell culture systems provide an 
environment in which cellular function is closer to in vivo than is observed using 
traditional two-dimensional (2-D) culture methods. Such models are ideally suited for 




first goal of this research was to generate a novel 3-D culture system that models the 
rodent brain in vitro and that is responsive to inflammatory stimuli. The cultures were 
comprised of primary neurons, astrocytes, and microglia derived from pre- and post-natal 
rat central neural tissue. Following optimization for cellular survival and confirmation of 
the inflammatory potential, the cultures were used to generate a model of mechanically-
induced neuroinflammation. The goal of this step was to create a reproducible 
inflammatory response from a prescribed mechanical injury. Further, the system was 
utilized to study some of the underlying molecular mechanisms which contribute to the 




 Injuries to the head by various means have long been a problematic occurrence, 
leading to lasting effects that manifest days, weeks, and even years after the insult. 
Clarification of the underlying processes responsible for the observed symptoms of TBI 
have only come in the last century as the field of neuroscience has developed. While the 
mechanics of injury in terms of the forces experienced by the skull and brain have been 
described using Newton’s laws and the material properties of the affected tissues [5, 6], 
they only account for the gross tissue damage in the acute phase of injury. This is crucial 
for predicting survival and disability as a result of TBI, but a complete picture of the 
factors in play requires an understanding of how processes at the cellular level are 
affected by mechanical injury. As the field of neurotrauma has advanced, it has become 




tissue damage. Rather, signaling cascades initiated in diverse cell types contribute to the 
complexity of the response. 
 The primary cellular components of the central nervous system (CNS) are 
neurons, astrocytes, microglia, and oligodendrocytes. Neurons are responsible for 
receiving, processing, and transmitting encoded information throughout the nervous 
system. Consisting of a cell body, signal-receiving dendrites, and signal-transducing 
axons, they have diverse morphologies that are dependent on function as well as 
anatomical location. Within the CNS, oligodendrocytes are the myelinating cells that 
provide axonal insulation for electrical signal transduction. The majority of the neuronal 
cell volume is contained outside of the cell body in the elaborate arborization of their 
processes which gives them a very high surface-area-to-volume ratio. While this allows 
for synaptic connections with other cells numbering orders of magnitude more than the 
number of the neurons themselves, it makes them a particularly vulnerable cell 
population due to the increased exposure to external stresses. Additionally, as they are 
post-mitotic cells, replacement of neurons can only be achieved through the 
differentiation of neuronal progenitor cells. In the acute phase following TBI, the 
mechanical loading can lead to increased membrane permeability and neuronal cell death. 
Subsequent effects include: diffuse axonal injury, cerebral ischemia, disruptions in ion 
homeostasis, and oxidative stress [7]. Astrocytes not only provide structural and 
nutritional support to neurons, but also participate in synaptic function [8] and blood-
brain barrier (BBB) formation. TBI induces reactive astrogliosis which is characterized 
by cellular hypertrophy, increased proliferation, and an upregulation in cytokine 




effectors of the CNS, actively sampling the environment and becoming activated upon 
sensing that an insult such as TBI has occurred. Similar to astrocytes, they have a reactive 
phenotype characterized by proliferation and increased cytokine production. The 
differential responses of these cell types and the accompanying disruption of the cerebral 
vasculature contribute to the complex tissue response following TBI. 
Perhaps the most confounding issue in the study of TBI is the heterogeneity of 
injury and injury response across the population. Modeling TBI is a difficult proposition 
due the variable severity and causes of injury, which include falls, vehicular accidents, 
concussive blasts, and sports-related injuries, among others. Cell and tissue-level events 
including cell death, astrogliosis, glial scar formation, BBB disruption, microglial 
activation, and inflammation can occur to varying degrees depending on injury severity. 
Further, the complexity of the cellular mechanisms underlying these events makes it 
difficult for a single model to be representative of all of the facets of the injury response 
[7, 10]. As such, many models isolate certain aspects of problem by either simplifying the 
injury mechanics or by targeting specific cellular populations. Unfortunately, no 
treatments that have shown promise in vitro or  in animal models have translated to 
clinically effective therapies [2, 3, 11, 12]. No system can fully represent the injury 
responses encountered in the clinical setting, but given the prevalence of TBI, research 
continues to push forward to develop a translational model. 
1.2.1.2 Epidemiology 
 TBI continues to be an ever-growing cause of morbidity and mortality throughout 
the developed world. With 1.7 million TBI events occurring every year in the U.S. alone, 




(concussion) events. The CDC estimates that nearly one-third of injury-related deaths are 
at least partially caused by TBI, averaging 138 per day. Concussions, caused mostly by 
falls and motor vehicle collisions, make up the overwhelming majority of events and 
affect upwards of 600 out of 100,000 people worldwide annually [13]. This number 
includes an estimate of undiagnosed/untreated concussions which more than doubles the 
assessment based on hospital data [13]. The fact that so many people fail to seek medical 
attention following a TBI not only limits the data for epidemiological study, but also 
exposes one of the major barriers to successful TBI therapy. The symptoms associated 
with a mild TBI, particularly sports-related concussions, may not be deemed serious 
enough to seek medical care [14]. Thus, accurate assessment and diagnosis represents a 
critical need in the field of TBI research as increasing evidence implicates the long-term 
effects of injury in delayed dysfunction. 
The effects of TBI are not limited to the acute tissue damage that occurs as a 
result of the injury. The long-term effects of TBI have come to national attention as they 
have manifested in soldiers returning from war [15, 16] and in former football athletes 
[17, 18]. Research has shown that underlying these long-term effects are secondary injury 
mechanisms rooted in inflammation that can contribute to deficits later in life [19-21] and 
to predisposition to neurodegenerative diseases such as Alzheimer's disease (AD) [22, 
23]. These developments are exacerbated by repeated insults, leading to a condition 
known as chronic traumatic encephalopathy (CTE) [17, 20, 23]. According to the CDC, 
CTE is defined as a progressively degenerative tauopathy that is distinct from AD, but 
that similarly involves tau protein and relies on postmortem assessment for definitive 




be the link between TBI and AD [24]. Although the bulk of media attention has focused 
on soldiers and athletes, the chronic inflammatory processes induced by TBI can affect 
any patient. Indeed, given that most TBIs result from falls and car accidents, the long-
term effects are a growing concern for the entire population and require increased 
research attention for the development of treatments. 
1.2.1.3 Clinical trials 
 Many clinical trials have focused on the protection of the vulnerable population of 
neurons in the acute phase after TBI. However, due to the variability of injury severity 
and BBB involvement, the time window in which therapeutic intervention is feasible is 
very narrow. Since any primary necrotic tissue damage directly caused by the initial 
insult is difficult to address in the acute phase of injury, efforts to curb secondary injury 
mechanisms such as edema, intracranial pressure increase, excitotoxicity, and 
inflammatory cascades have been the primary goal. Phase III clinical trials from decades 
ago that included administration of drugs such as mannitol, barbiturates, nimodipine, 
PEG-SOD, and Selfotel showed no effect or overall benefit as a result of treatment [11, 
12]. Physical methods of intervention such as induced hypothermia, while promising in 
Phase II trials, did not significantly affect outcome in Phase III trials [3]. More recently, 
progesterone administration following injury showed promising early results [25, 26], but 
failed to demonstrate clinical benefit in large-scale human trials [27, 28]. Clinical trials 
are ongoing for various treatments, but it is clear that there is a chronic issue of 
translational failure of TBI therapies. 
The lack of success in the development of effective clinical therapies for TBI 




successful in vitro and in vivo therapies to the clinic due to the inherent differences in 
physiological response between small mammals and humans. Second, the heterogeneity 
of TBI and the response-based clinical assessment measures make for a murky picture of 
the underlying physiological dysfunction requiring treatment [29, 30]. Third, the narrow 
therapeutic window of TBI limits the feasibility of early intervention. Thus, some 
pharmaceutical treatments may have failed due to improper timing of administration [2]. 
This leads the need for an increase in the number of TBI clinical trials as they are far 
outpaced by those for related diseases such as stroke [31]. Finally, the design of 
translational studies needs to be based on sound pre-clinical in vitro and animal studies to 
maximize the potential for success [31]. Such a need could be addressed using systems 
that more accurately model the tissue environment following injury. 
1.2.1.4 Pre-clinical experimental research 
 Recreating TBI in an in vivo animal model is a difficult proposition due to the 
complexity of the injury parameters. The forces experienced by a human body upon 
falling or during a motor vehicle collision are proportional to body mass. In order to 
generate forces upon an animal that are commensurate with those that impart injury to 
human brain tissue, the deceleration to impact would have to be of substantially greater 
magnitude. Therefore, most animal models of TBI tend to isolate a component of the 
injury mechanism and to deliver the insult such that comparable injury results in the 
animal. Typical animal models of TBI are controlled cortical impact (CCI), fluid 
percussion, and weight drop [32, 33]. Of these, the latter is the simplest, relying on 
gravitational acceleration of a weight through a guidance tube to deliver a closed-head 




initial height of the weight. Closed-head injuries are particularly difficult to characterize 
due to the heterogeneity introduced by the intact skull and head position. For this reason, 
a more recent injury model utilizing pneumatic impact of the unconstrained heads of 
mice incorporates high-speed imaging in order fully define the kinematics of closed-head 
injuries [35]. CCI is a more focused method of injury that utilizes a pneumatically-driven 
piston to injure the exposed brain [36]. Different levels of injury severity can be achieved 
by adjusting the velocity of the piston or the depth to which it impacts the tissue. Fluid 
percussion is the most well-characterized injury method and is an open-head injury that 
uses a pendulum to strike a piston adjacent to a fluid reservoir to generate a hydraulic 
pulse [37]. Injury severity is adjusted by the height of pendulum release. Fluid percussion 
injury can be used to model both focal and diffuse brain injury. While these as well as 
other methods of injury [33] have generated successful results in animals, there is 
concern as to what processes they are truly capable of modeling and how these translate 
to TBI events in humans [38, 39]. 
TBI has also been modeled in vitro using organotypic slice cultures as well as in 
2-D and 3-D cell culture systems [40]. A major advantage of using slice cultures rather 
than dissociated cells is that the anatomy of the tissue is preserved. Organotypic slice 
cultures are simply thin sections of intact mouse or rat CNS tissue maintained in a culture 
environment for a period of time. The slices are most commonly hippocampal, but whole 
coronal, cortical, and thalamic slices have also been used [40]. Injuring tissue slices can 
be accomplished using a weight drop or impactor but can also be achieved by culturing 
the slices on a silicone membrane to which a prescribed biaxial strain can be applied [41, 




comparable to in vivo injury [43]. The major disadvantages associated with organotypic 
slice cultures are maintaining cell viability and cellular organization. A study comparing 
mouse whole brain slices from neonatal and adult animals showed that although the 
neonatal tissue exhibited greater viability, there were significant structural changes in the 
neuronal and glial populations [44]. Thus, neonatal tissue is typically favored for slice 
cultures although it may not maintain its anatomical structure which is the major 
advantage of this method. 
Dissociated primary cells can be cultured in 2-D or 3-D applications for the 
purpose of modeling TBI in vitro. In 2-D culture systems, injury to neurons or to neuron-
astrocyte co-cultures can be achieved by applying uniaxial or biaxial strain to cells 
cultured on a flexible membrane similar to that described for the hippocampal slice 
cultures [45, 46]. This and similar flexible membrane-based methods are by far the most 
common for 2-D in vitro TBI models as cells cultured as a monolayer on a rigid substrate 
require an injury method such as fluid shearing [47]. Culturing primary neural cells in 3-
D matrices greatly expands the options for mimicking TBI in vitro as the hydrogel in 
which they are cultured creates a tissue-like environment to which compression and shear 
can be applied. The choice of matrix depends on the desired mechanical properties and 
can also dramatically affect cell survival and morphology. Examples of biologically inert 
scaffolds include: agarose [48], alginate [49], self assembling peptide nanofibers [50-53] 
(e.g. RADA16), and silk fibroin [54, 55]. Examples of bioactive scaffolds include: 
extracellular matrix (ECM) proteins such as collagen and laminin [56], biologically-
derived matrices such as Matrigel™ [57], and functionalized scaffolds that have had 




promote cellular interaction [58]. The scaffold most commonly used in our lab is 
Matrigel™, which is derived from EHS tumors grown in mice and consists primarily of 
laminin, collagen IV, and heparan sulfate proteoglycan (HSPG) [57]. Neurons as well as 
neuron-astrocyte co-cultures grown in Matrigel™ scaffolds have been subjected to bulk 
shear [59-61] and compression [62] injuries using custom-made injury devices. The in 
vivo-like geometry afforded by 3-D culture more accurately reproduces the mechanical 
loading experienced by tissue in vivo. 
Modeling TBI in vitro rather than in vivo has the advantages of higher throughput, 
increased homogeneity within samples, and consistency between samples. The downside 
is that it is even more difficult to capture the complexity of the full cell and tissue 
response since the system has been stripped down to one or two cell types. It is certainly 
debatable whether sacrificing complexity for control is a worthy exchange. However, if 
specific cell signaling pathways of interest can be accurately replicated, in vitro models 
can be powerful tools for studying diseases such as TBI. 
1.2.2 Neuroinflammation 
1.2.2.1 Introduction 
Inflammation in the CNS shares many of the same characteristics as the innate 
immune response in the rest of the body in terms of the signaling pathways that are 
involved [63]. However, the CNS is literally set apart by the presence of the BBB. This 
complex interface regulator renders the CNS "immune privileged," meaning that if the 
integrity of the BBB is maintained, passage is limited to nutrients and molecules small 
enough to enter. Since the BBB is not readily permeable to antibodies and tightly 




mechanisms of acquired immunity. It therefore falls to resident cells to carry out an 
inflammatory response to an insult.  
 Astrocytes, comprising the highest proportion of cells in CNS, become reactive in 
response to injury and contribute to the inflammatory response through the release of 
cytokines, proliferation, and scar formation [64]. It is microglia, however, that act as the 
sentinels of the brain. They achieve this role by constantly sampling their environment 
for signals indicating any form of injury [65, 66]. If detected, they can rapidly respond by 
releasing cytokines, acting as macrophages, or even by mobilizing to the injury site and 
proliferating [67]. As such, they are considered to be the immune system of the CNS. 
Astrocytes and microglia are also key players in a BBB-breaching event. Both cell types 
attempt to create a barrier around the insult to mitigate the damage caused by the 
presence of blood and the resulting infiltration of lymphocytes. In the case of severe 
infection, microglia can additionally act as antigen presenting cells to the invading 
lymphocytes [68]. Although isolated from the rest of the body, the CNS has the means of 
mounting an innate immune response to an insult as well as the ability to interact with the 
acquired immune system in the event of a BBB breach. 
1.2.2.2 Cytokines and other signaling molecules 
 At the heart of inflammatory signaling are cytokines, polypeptides that are rapidly 
released after insult to stimulate a response from other cells. Included in this class of 
molecules are interleukins, interferons, tumor necrosis factors, chemokines, and certain 
growth factors [69]. Cytokine release can induce pro- inflammatory or anti-inflammatory 
responses in an autocrine or paracrine manner. Key pro-inflammatory cytokines include 




inflammatory cytokines include IL-10 and tumor growth factor-β (TGF-β). It should be 
noted that both pro- and anti-inflammatory activities are known to be exhibited by 
cytokines such as IL-1 [70] and IL-6 [71] depending upon the location in the body and 
the nature of the signaling trigger. Cytokine release is a rapid process as many exist as 
immature molecules that are cleaved into mature, active forms in response to injury [69]. 
Inflammatory cytokines appear to be integral to the pathophysiology of TBI [72], and are 
attractive candidates for biomarkers [73] as well as for therapeutic intervention [74]. 
 One of the most well studied cytokine families is that of IL-1. This group of 
proteins consists of IL-1α and IL-1β as agonists of the IL-1 receptor and IL-1 receptor 
antagonist (IL-1ra) as a competitive inhibitor of the IL-1 receptor [74]. Il-1β is of 
particular interest in the study of neuroinflammation as it is released in response to a 
variety of insults. The immature, pro-form of IL-1β is activated by enzymatic cleavage by 
interleukin converting enzyme (ICE, also known as caspase-1), which produces a mature, 
active molecule that is released from the cell [69]. While release of mature IL-1β has 
been triggered by exposure to the bacterial endotoxin lipopolysaccharide (LPS) in both in 
vivo [75] and in vitro [76] studies, the role of ATP signaling mediated by purinergic 
receptor transmission has expanded the understanding of the control of this mechanism 
[77-79]. However, this is not the sole mechanism by which activation can occur. IL-1β 
plays a major role in the innate immune response and its immature form has been shown 
to be cleaved extracellularly by a neutrophil enzyme [80]. In the context of 
neuroinflammation, the caspase-1-mediated cleavage pathway is of particular interest as 
it is the primary mechanism activated by acute infection as well as by injuries such as 




release is dependent upon the formation of an inflammasome, a large multi-protein 
complex that forms in response to microbial presence, injury, or metabolic disruption, 
and recruits caspase-1 [63]. 
 Additional pro-inflammatory species released primarily by microglia are reactive 
oxygen species (ROS) and nitric oxide (NO) [9]. Both are free-radical molecules, but 
whereas ROS such as superoxide bear their lone electron on an oxygen atom, NO bears it 
on a nitrogen atom. Superoxide and NO are generated by the enzymes NADPH oxidase 
and inducible nitric oxide synthase (iNOS), respectively. While they do not fall into the 
category of cytokines, they are key players in the more toxic cascades of 
neuroinflammation [84]. Neurotoxicity has been observed as a result of the presence of 
both superoxide [85] and NO [86] induced by TBI in vivo and by a combination of LPS 
and interferon gamma (IFN-γ) in vitro, respectively. However, another in vitro study 
found that increased neuronal death in neuron-glia co-cultures required paired stimulation 
of both NADPH oxidase and iNOS [87]. These varied outcomes indicate that 
neuroinflammation is a complex interplay of cellular signaling that is highly dependent 
on the system used for study. 
1.2.2.3 In vivo and in vitro models 
 Neuroinflammation in response to TBI has been studied for decades in the clinical 
setting as well as in animal models [72]. The importance of cytokine signaling in the 
secondary injury mechanisms following TBI have made them prime targets for study in 
both in vivo and in vitro systems. In particular, IL-1β has been the focus of TBI-induced 
inflammation in animal models [64]. The effect of TBI on IL-1β release in rats has been 




cortical impact (CCI) [89], fluid percussion [82, 90], and long-term probe implantation 
[75]. With the weight drop and fluid percussion models, levels of IL-1β protein and 
mRNA increased within hours after injury, while a delayed release (24-48 hours) of IL-
1β protein was observed in the milder probe implantation model. Time points earlier than 
24 hours were not reported for the CCI model. Compared to the abundant in vivo studies 
of neuroinflammation, there is a relative paucity of in vitro studies. Chemical stimulation 
with a combination of LPS and IFN-γ-induced increases in TNF-α, IL-6, and NO in co-
culture models consisting of primary neurons and either primary microglia or a microglia 
cell line [91]. A weight drop injury model of mouse organotypic slice cultures was found 
to cause an increase in IL-1β mRNA expression that peaked 4 hours after injury [92]. 
Exposure of various astrocyte, microglia, and brain endothelial cell lines to IL-1β caused 
an increase in mRNA levels of IL-6 and a number of chemokines [93], demonstrating the 
downstream pro-inflammatory activity of IL-1β. Although there are many fewer in vitro 
studies, one important comparison to make with the in vivo results is the timeline of 
cytokine release. The in vivo weight drop and fluid percussion methods of TBI 
demonstrated detection of elevated IL-1β protein between 3 and 8 hours after injury [82, 
88] and IL-1β mRNA as early as 1 hour after injury [90]. The 4 hour peak of IL-1β 
mRNA in injured hippocampal slice cultures agrees with these data [92]. Regardless of 
the specific timeline for each study, cytokines were detected within the first 24 hours 
after injury. This information is critical to the design of future in vitro systems. 
As with any inflammation, the case of neuroinflammation brings up the question 
as to whether the response is ultimately helpful or harmful to the damaged tissue. Indeed, 




and their release of anti-inflammatory cytokines [4, 95] promote healing pathways. 
However, their pro-inflammatory signaling and cytotoxicity mediation can promote 
further damage. Neuroinflammation, and specifically microglia, represent an enticing 
target for therapeutic intervention, but methods for achieving this remain elusive due to 
the poor understanding of the graded injury response. An ideal treatment would permit 
the initial beneficial inflammation, while limiting the prolonged, potentially chronic 




 Microglia are small, dynamic cells of the CNS with diverse immune-related 
function. Since first described by Pío del Río-Hortega in 1919, microglia have become an 
increasingly popular subject for biomedical research. The function, and consequently the 
origin of microglia has been studied since their identification. Although they carry the 
term "glia" in their name, determination of their origin has confirmed del Río-Hortega's 
assertion that they arise from the mesoderm, rather than from the ectoderm [68, 96]. They 
exhibit characteristics and markers of various cell types arising from the middle germ 
layer including dendritic cells and macrophages [97, 98]. Recent research has traced the 
lineage of microglia to primitive macrophages in the yolk sac [99], and more recently, a 
specific erythromyeloid precursor has been identified [100]. Due to the developmental 
disparity between microglia and the other cells of the CNS, questions quickly arose as to 
how and when they appear in the brain. Studies have determined that very early in 




as a self-maintaining population [99, 101, 102]. Despite the extensive research focused 
on microglia, a complete understanding of their function is still lacking. 
1.2.3.2 Function 
 Microglia compose approximately 10-20% of the adult glial cell population [103]. 
They are capable of multiple functions, such as macrophage-like scavenging, antigen 
presentation, and rapid proliferation and cytokine release (IL-1, IL-6, TNF-α, TGF-β1, 
etc) in response to various insults [68, 76, 95]. Microglia exhibit both neuroprotective and 
cytotoxic characteristics depending upon the biological context [104, 105], rendering 
their role in the CNS paradoxical. Microglia exist in one of at least two morphologically 
and functionally distinct states in vivo, known as the ramified (quiescent) and the 
amoeboid (activated) states. In the ramified state, the microglia are characterized by a 
small soma and an extensive network of processes. Although considered "quiescent," it 
has been shown that ends of the processes of these cells are highly motile and are actively 
sampling the local environment [65, 66, 96]. In response to stimuli (ATP from dying 
cells, ROS, pro-inflammatory cytokines, etc.), microglia release cytokines and 
chemokines, extend processes toward an area of insult [65], or retract their processes and 
transition to the activated, amoeboid morphology. In the amoeboid state, microglia can 
migrate along chemokine gradients towards an injury site and rapidly proliferate [96]. 
Their extensive expression throughout neural tissues and their diverse ability to sense and 
respond to environmental cues ideally place microglia in the role of sentinels of the CNS. 
1.2.3.3 Purinergic receptors in microglia 
Purinergic receptors are a large class of ubiquitously expressed surface receptors 




well as pyrimidine derivatives such as UDP and UTP are agonists [106]. The many 
members of this receptor family are subdivided into three main groups. The P1 receptors 
are metabotropic and stimulated by adenosine. The P2X receptors are ionotropic and 
mostly stimulated by ATP. The P2Y receptors are metabotropic and are stimulated by 
ADP, ATP, UDP, or UTP, depending on the subtype. Due to their extensive expression 
throughout the body and the availability of their agonists, purinergic receptors are 
responsible for a very diverse array of functions. 
 Of particular interest is the role that purinergic signaling plays in microglial 
function. The G-protein coupled P2Y6 and P2Y12 receptors are integral to microglial 
phagocytic activity [107] and to the mechanism of process extension [108], respectively. 
However, one of the most studied purinergic receptors in microglia is the P2X7 receptor. 
Expressed in microglia, astrocytes, and debatably in neurons [109], the receptor functions 
as a cation channel with ATP-stimulated ion channel opening [106]. Typically, the cation 
channel is composed of a homotrimeric conformation of P2X7 receptor subunits and it is 
particularly permeable to calcium under normal stimulation conditions [110]. Upon 
chronic activation with ATP, pore dilation occurs, reducing the selectivity of the channel 
and allowing molecules up to 900 Da to pass through [111]. The role of this large pore 
formation is not well understood. It can lead to apoptosis, resulting in it being referred to 
as a "death receptor" [112, 113]. However, there is debate as to whether stimulation 
conditions sufficient to induce cell death occur in vivo [114, 115].  
 Perhaps the most studied aspect of the P2X7 receptor is its role in the processing 
and release of IL-1β [77-79, 116]. This is a key function of microglia as IL-1β release is 




P2X7 receptor results in conversion of IL-1β from an immature to a mature form by 
caspase-1, followed by its release from the cell. This process is inflammasome-mediated, 
and involves signaling through pannexin-1, a protein which has also been implicated in 
P2X7 pore formation [118, 119]. Due to the high level of expression in microglia [120] 
and its involvement with ion transport, cytokine release, and cell death, the P2X7 receptor 
represents a potential therapeutic target in diseases involving neuroinflammation [121, 
122]. Indeed, purinergic signaling has recently been shown to play a role in TBI through 
calcium wave propagation in astrocytes [123]. A better understanding of the role this 
receptor plays in microglia and how alteration of its signaling may affect the cells could 
lead to promising new treatments for TBI. 
1.2.3.4 Studying microglial injury 
 Performing studies on microglia in vivo and in vitro each presents its own set of 
challenges. Because many microglia responses can be transient, the typical method of 
exposing animals to a particular treatment and subsequently sacrificing them at various 
time points only provides a glimpse into the dynamic characteristics of these cells. This 
traditional method has been used to study the early development of microglia [124] as 
well as to assess cellular response to in vivo injury [125]. However, in vivo imaging 
provides a much better picture of how these cells respond in real-time. Using a thinned-
skull preparation on mutant mice to image GFP-positive cortical microglia with two-
photon confocal microscopy, it has been demonstrated that the processes of microglia are 
highly motile in the resting state and that they rapidly extend to surround the focal region 
of a laser ablation injury [65, 126]. Additionally, it was shown that application of ATP to 




Further study of resting microglia using a similar method revealed that the processes 
make contact with synapses and that the contact duration is dependent on the functional 
state of the synapse [66]. All of these microglial responses were rapid (on the order of 
minutes), thus elucidating previously hidden cellular behavior. 
 The difficulty underlying in vitro studies of microglia centers around maintaining 
their dynamic nature once isolated from CNS tissue. As evidenced by the constant 
movement of their processes and potential for rapid response to insult, removing 
microglia from their cellular and matrix signaling sources may limit their ability to 
exhibit in vivo function in vitro. Primary microglia in mixed cortical cultures from 
embryonic rats are initially few in number with a mostly rounded morphology, but later 
proliferate and exist as a mixed population of both rounded and process-bearing cells 
[127]. Isolation of primary rat microglia can be achieved by agitating confluent mixed 
neonatal glial cultures in which microglia are loosely adhered to the dense lawn of 
astrocytes [128]. This harvesting process has been performed repeatedly on the same 
cultures of mouse mixed glia without the loss of phenotype [129]. However, once 
isolated, the proliferation rate of microglia is very low compared to when co-cultured 
with mitogen-producing astrocytes. Other options for in vitro study include immortalized 
cell lines (such as BV-2), adult microglia, and organotypic slice cultures. However, each 
method carries its own inherent advantages and disadvantages [130]. 
 In vitro studies have further implicated ATP in pro-inflammatory microglia 
responses.  Primary rat mixed glial cultures treated with ATP exhibit increased IL-1β 
release and endogenous astrocyte-derived ATP is a key factor for inducing microglial 




stimulation with either ATP or benzoylbenzoyl-ATP (BzATP) (a highly potent P2X7 
receptor agonist) resulted in neuron-specific cell death [115]. Isolated microglia have also 
been studied in vitro to explore the mechanisms underlying process retraction following 
insult. Using isolated primary GFP-positive mouse microglia grown on a thin layer of 
Matrigel™, real-time imaging has shown that LPS-treated microglia were repelled by 
ATP stimulation while untreated microglia were attracted to it [132]. Further, it was 
determined that process retraction of activated microglia was mediated by the adenosine 
A2A receptor, a process that was confirmed to also occur in human microglia [132]. ATP-
induced process extension by rat microglia into collagen gels has also been demonstrated 
in vitro [133]. While these studies have provided a deeper insight into the mechanisms 
underlying characteristic microglial behavior, there remains a great deal of work to 
capture the complexity of the in vivo injury response in an in vitro system. 
 Microglia are the key immune effectors of the CNS, and are therefore a potential 
target for the therapeutic intervention in neurodegenerative diseases, and particularly in 
TBI [20, 134, 135]. From the initial release of both pro-inflammatory and anti-
inflammatory cytokines to proliferation and clearing of dead cells and debris, the 
microglial response to TBI is critical to recovery [67]. As microglia have been shown to 
exhibit these functions in culture [91, 129, 136], an in vitro model of neuroinflammation 
must include these cells in order to fully capture the events that may lead to the long term 
effects of TBI. 
1.3 Research outline 
 The goal of developing an in vitro model of neuroinflammation for studying 




specific aims. This section of the dissertation is the conclusion of the introductory 
chapter. Aims 1A and 1B describe the development and characterization of a novel 3-D 
multitypic neural cell culture system and its ability to model neuroinflammation. These 
aims are presented in Chapters 2 and 3, respectively. Aims 2A and 2B describe the 
adaptation of an in vitro mechanical injury model for these cultures and its 
implementation in studies of mechanically-induced neuroinflammation. These aims are 
presented in Chapters 4 and 5, respectively. A discussion of the injury model and its 
limitations as well as of the future directions for the novel culture system is presented in 
Chapter 6. 
 
1.3.1 Specific Aim 1A. Develop a robust neural 3-D culture system to generate an in vitro 
representation of rat cortical tissue  
1.3.1.1 Objective  
Develop and characterize a 3-D multitypic culture system which incorporates 
primary microglia in addition to neurons and astrocytes.  
1.3.1.2 Approach 
 Mixed glial cultures from neonatal rats were grown in a manner that favors the 
proliferation of both astrocytes and microglia. These cells were combined with 
embryonic rat-derived neurons and dispersed in a 3-D gel of ECM proteins to generate a 
culture which was representative of the in vivo rat cortex. Specific phenotypic markers 
were used to verify the presence of a mature cell types. Assessment of cell viability at 





1.3.2 Specific Aim 1B. Demonstrate induced inflammation in 3-D multitypic neural cell 
cultures 
1.3.2.1 Objective  
Use a pro-inflammatory stimulus to induce the release of known markers of 
inflammation in vitro.  
1.3.2.2 Approach  
Chemical stimulation of the 3-D cultures in the form of LPS was used to induce a 
pro-inflammatory microglial phenotype, the achievement of which was assessed by 
changes in cell morphology, changes in levels of mRNA expression of key cytokines, the 
release of pro-inflammatory cytokines such as IL-1β, and the generation of NO. 
 
1.3.3 Specific Aim 2A. Adapt an in vitro mechanical injury model of TBI for 3-D 
multitypic neural cell cultures 
1.3.3.1 Objective  
Subject 3-D multitypic neural cultures to mechanical deformation to recreate the 
effects of cortical injury in vitro. 
1.3.3.2 Approach  
Custom-made shear and compression devices were used to injure the 3-D 
cultures. Shear injury was imparted at a range of strains and strain rates with the goal of 
reducing the viability of a subpopulation of cells within the culture. Compression injury 
was imparted with a piston traveling at a range of velocities to specified depths in order 





1.3.4 Specific Aim 2B. Demonstrate mechanically-induced neuroinflammation in 3-D 
multitypic neural cell cultures 
1.3.4.1 Objective  
Subject multitypic neural 3-D cultures to a mechanical insult to model TBI in 
vitro to induce an inflammatory response by the microglia and compare this to the 
chemically-induced response. 
1.3.4.2 Approach  
Intracellular and extracellular protein levels of the pro-inflammatory cytokine IL-
1β were assessed by various immunological methods to determine the state of 
inflammation in the culture at various time points post-injury. mRNA levels of IL-1β as 
well as other inflammatory cytokines were determined to obtain a more detailed picture 
of the mechanical injury response at the genetic expression level. Additionally, the 
generation of NO and ROS in response to injury was measured. The outcome measures 
of these studies were compared to the response of the cultures to chemically-induced 






DEVELOPMENT OF A 3-D MULTITYPIC NEURAL CELL CULTURE SYSTEM 
2.1 Introduction 
The initial goal of this research was to generate a neural cell culture system that 
better approximated the composition of living cortical tissue than previous models 
through the inclusion of neurons, astrocytes, and microglia. Creating a reliable in vitro 
representation of living mammalian tissue is a difficult task in which many compromises 
must be made. Physical limitations of a synthetic system and the absence of other 
interacting organs and organ systems contribute to the artificiality of the construct. At the 
most basic level, in vitro research utilizes primary or immortalized cells grown in a 
monolayer on a rigid plastic or glass surface. Atmospheric oxygen levels are required to 
overcome diffusion limitations which must be addressed due to the lack of a circulatory 
system for oxygen transport. Specifically, the atmospheric partial pressure of oxygen 
limits its diffusion rate through the cell culture medium thereby limiting the available 
oxygen for cellular respiration. Carbon dioxide is delivered at a concentration much 
higher than atmospheric levels to maintain pH balance through the bicarbonate buffering 
system present in living mammals. Again, the lack of active transport in the system 
necessitates this condition. These issues are further compounded with increasing cell 
density as the demand for oxygen and nutrients increases proportionally. However, to 
achieve a more physiologically relevant in vitro model, closer approximations of cell 
density and the ECM environment must be created. 
3-D cell culture models have the distinct advantage of providing a support matrix 




advantage come further diffusion limitations for oxygen and nutrient delivery. In the case 
of neuronal cultures, this is a critical problem. Culturing neurons in vitro requires a host 
of medium additives to ensure cellular survival and function. Unlike dividing cells such 
as fibroblasts or even astrocytes, the number of primary neurons grown in a dish will not 
increase. As such, the goal is to slow the decline and death of the cells in the population 
for as long as is necessary for experimentation. This can be a very difficult task since 
neurons in vivo have an extensive support network composed of other cell types. 
Co-culturing neurons with astrocyte feeder-layers has long been a common 
method for improving neuronal survival and function [137, 138]. Typically, neurons and 
astrocytes are grown on separate 2-D surfaces closely apposing each other. The 
separation is required since the dividing astrocytes could overwhelm the neurons were 
they to be grown together on the same surface. 3-D culture systems allow for multiple 
cells types to be grown together and for them to interact in a manner that more closely 
resembles the in vivo brain in terms of geometry and connectivity. 3-D co-cultures have 
been used in our lab to study TBI in vitro [60, 62]. However, while a co-culture model 
used in this field can aptly reproduce the in vivo injury response of neurons and 
astrocytes, it is limited in scope as there is minimal representation of injury-induced 
inflammation which leads to secondary tissue damage and potential long-term injury 
effects. 
Absent from previously studied 3-D culture systems containing neurons and 
astrocytes are microglia, the myeloid-derived immune effectors of the CNS. As discussed 
in Chapter 1, microglia not only play a crucial role in mounting an inflammatory 




normal brain. Therefore, a cell culture model of neural tissue must necessarily contain 
microglia if it is to accurately represent the brain in both resting and injured states. The 
goal of the work presented here is to produce such a representation through optimization 
of methods to generate viable, 3-D multitypic cultures consisting of neurons, astrocytes, 
and microglia. 
2.2 Neuron and astrocyte 3-D co-culture model 
 The previous co-culture model utilized by our lab was intentionally designed to 
eliminate microglia due to their unfavorable reputation as a confounding presence in 
neural cell culture studies [139]. The neurons for these cultures were generated from the 
cortical tissue of embryonic day 18 (E18) rat fetuses. These cells were combined with 
purified astrocytes generated from postnatal day 0 or 1 (P0 or P1) rat pups. The 
purification procedure was adapted from a protocol published by McCarthy and deVellis 
[140]. Briefly, the mixed glial cultures were grown to confluence with agitation manually 
applied at each feeding to dislodge microglia and oligodendrocytes. Cells were passaged 
a minimum of four times prior to use in co-cultures and were not maintained beyond the 
tenth passage. The cells were combined at specified ratios, suspended in Matrigel™, and 
plated in 3-D to a thickness of between 0.5 and 1.0 mm. Complete culture methods can 
be found in Appendix A. 
 These co-cultures were used in mechanical injury studies using custom-made 
devices discussed in Chapter 4. These studies were designed to examine the effects of 
injury type (shear or compression) and severity (strain and strain rate) on outcome 
measures such as cell viability [60, 62], induced astrogliosis [60], and membrane 




model were strain and strain rate dependent. These findings provided insight into some of 
the mechanisms underlying the acute cell response to mechanical injury.  
As with any in vitro system, the co-culture model has limitations. Although many 
aspects of the acute mechanical injury response are effectively represented, the absence 
of microglia in the culture eliminates the major inflammatory component. Microglia not 
only play a role in the acute injury phase, but are central players in the chronic phase of 
injury which leads to initiation of secondary injury cascades and potential long-term 
ramifications such as neurodegenerative disease. Therefore, in order to more fully model 
injury-induced mechanisms in vitro, it is necessary to include these cells. 
2.3 Neuron, astrocyte, and microglia 3-D multitypic culture model 
 The overall goal of developing a 3-D multitypic neural cell culture system is to 
create an in vitro representation of cortical brain tissue that can effectively model the in 
vivo responses to injurious stimuli. With that in mind, the specific objectives for the 
culture model must be established. First, all three cell types: neurons, astrocytes, and 
microglia must be present throughout the range of time points from which data will be 
taken (7-14 days). Second, the viability of the cells in the culture must be high at these 
same time points. If there is a preponderance of cell death in naïve cultures, this would 
certainly confound the assessment of cellular response post-injury. Finally, the culture 
should be responsive to stimuli that elicit inflammation in other models. The first two 
objectives will be addressed in the next sections. The latter will be addressed in Chapter 
3. In order to achieve these objectives, an iterative process of culture development and 





2.3.1 Initial method: augment previous co-culture model with the addition of microglia 
 The first 3-D multitypic cultures ultimately required three separate dissections of 
cortical tissue to generate neurons, astrocytes, and microglia. The initial step in the 
development of the culture system was to become proficient at the established techniques 
for generating 3-D co-cultures of neurons and astrocytes. As previously mentioned, and 
described in detail in Appendix A, neurons were acquired from dissociated cortical tissue 
from E18 rat embryos. Astrocytes were acquired from dissociated cortical tissue from P0-
P1 rat pups and were purified through agitation and passaging a minimum of four times 
and a maximum of ten. The mechanical agitation serves to remove “contaminating” 
microglia and oligodendrocytes to produce a pure population of astrocytes. These cell 
types tend to grow loosely attached to the surface of astrocytes. Microglia, in particular, 
will begin to proliferate once a confluent bed of astrocytes has been established. It is this 
characteristic that was exploited in the first attempt at generating the multitypic cultures. 
 For many years, published research has described a simple method for harvesting 
microglia from mixed glial cultures derived from neonatal rats [76, 128, 140, 141]. 
Briefly, mixed glial cultures from rats aged P0-P4 were maintained for up to two weeks 
and subsequently shaken to remove the loosely adherent cells to the medium. These 
detached cells were then plated separately as a purified population of microglia. Thus, the 
first method to incorporate microglia in the neuron-astrocyte co-cultures was to generate 
a parallel set of glial cultures from which the microglia could be harvested. P0-P1 pups 
were used to generate a colony of purified astrocytes. P0-P4 pups were used to generate 
glial cultures from which the microglia were harvested. Finally, E18 embryos were used 




plating to ensure a high viability of neurons. Thus, the timing of the microglia dissection 
and the expansion of the astrocytes was critical to ensure sufficient cellular material was 
available.  
 On the day of 3-D plating, the neurons were harvested from E18 embryos, 
microglia were shaken from the mixed glial cultures, and astrocytes were trypsinized and 
collected from enough flasks to give the desired number of cells. Neurons, astrocytes, and 
microglia were combined at a ratio of 5:5:1, respectively. The cells were then suspended 
in high-concentration, growth factor-reduced Matrigel™ to a final matrix protein 
concentration of 7.5 mg/mL and to a final total cell concentration of 4,000 cells/mm3. 
The cultures were then plated into either custom-made 3-D culture chambers (see Section 
4.2.2.1) or into commercially available multiwell plates to a thickness of either 0.5 or 1.0 
mm. Regardless of the chamber used, the surface was coated with 100 μg/mL poly-D-
lysine (PDL) (Sigma-Aldrich, St. Louis, MO) for 24-48 hours. This is a higher 
concentration and longer coating time than typically used for 2-D cultures, but it was 
observed that the gel remained more adherent after two weeks in vitro using these 
conditions. While the astrocyte and mixed glial cultures were fed with DMEM/F12 (Life 
Technologies, Carlsbad, CA) containing 10% fetal bovine serum (Atlanta Biologicals, 
Norcross, GA), the medium for the 3-D multitypic neural cultures was serum-free to 
inhibit glial proliferation. 3-D cultures were maintained in Neurobasal medium 
supplemented with L-glutamine as well as with B-27 and G-5 supplements (all from 
Gibco®/Life Technologies/Invitrogen). B-27 supplement promotes the survival of 
primary neurons in vitro [142] and G-5 supplement is conducive to glial survival in the 




 The limiting factor in the number of 3-D cultures generated using this method was 
the yield of microglia. While more mixed glial cultures could be plated to produce more 
microglia, the resulting cost of maintenance would not have been justified by the modest 
increase in yield. Rather, the method was modified to incorporate exposure to 
macrophage colony stimulating factor (M-CSF) (Life Technologies), a secreted cytokine 
that, among other functions, promotes macrophage and monocyte proliferation and has 
been shown to induce proliferation in adult mouse microglia in vitro [144]. As microglia 
develop from a monocyte lineage, they also proliferate in response to stimulation with 
this cytokine. When mixed glial cultures were exposed to M-CSF (100 ng/mL), the 
increase in the number of loosely adherent, phase-bright microglia atop the astrocyte 
monolayer was easily observed after just 24 hours. The effect peaked around 48 hours 
and was not substantially enhanced with exposure to fresh M-CSF. Treatment of mixed 
glial cultures with M-CSF 48 hours prior to harvest for 3-D plating resulted in a sufficient 
yield for 3-D culture experiments. 
 Immunocytochemistry performed on the 3-D cultures after 13 days in vitro (DIV) 
revealed that the cultures indeed contained neurons, astrocytes, and microglia as 
indicated by positive labeling with antibodies against microtubule-associated protein 2 
(MAP2) (1:400, Chemicon/EMD Millipore, Billerica, MA), glial fibrillary acidic protein 
(GFAP) (1:1,000, Chemicon/EMD Millipore), and ionized calcium binding adaptor 
molecule-1 (Iba1) (1:1,000, Wako Chemicals USA, Inc., Richmond, VA), respectively. 
At 13 DIV, the cultures were fixed with paraformaldehyde, embedded in optimal cutting 
temperature compound (OCT™, Sakura Finetek USA, Inc., Torrance, CA) and cut into 30 




slides and processed for immunocytochemistry. Fluorescent images were acquired using 
a Nikon Eclipse 80i upright microscope (Nikon Instruments, Melville, NY) equipped 
with a MicroFIRE camera (Optronics®, Goleta, CA). Most of the positively labeled cells 
appear to be astrocytes and microglia as evidenced by the colocalization of the nuclear 
counterstain with the GFAP and Iba1 immunolabeling (Figure 2.1). This is a qualitative 
assessment indicating that despite the majority of the cells being neurons at the time of 
plating, the culture developed into one that contains a higher proportion of glial cells. 
This is likely due to both cell death from the freshly dissociated E18 tissue as well as 
from some proliferation occurring in the glial population. The latter would presumably be 
occurring at a rate far below that of a serum-containing culture, but would nonetheless 
contribute to the shift in cellular ratio. This “stabilized” ratio of neurons to glia is 
consistent with what one would expect in cortical tissue in vivo [145].  
 In addition to confirming the cell types present in the 3-D cultures, the viability of 
the cultures was also assessed. This was achieved either by labeling live and dead cells 
with calcein AM and ethidium homodimer (Sigma-Aldrich), respectively, or by labeling 
the nuclei of all cells present as well as those of dead cells using Hoechst 33342 and 
propidium iodide (Molecular Probes®/Life Technologies), respectively. Fluorescent 
images of intact rather than sectioned cultures labeled with these reagents were acquired. 
Cell counts were determined by first generating thresholded images in Adobe Photoshop 
CS4 (Adobe Systems, Mountain View, CA) and subsequently counting cells or nuclei 
using ImageJ. Cell viability using calcein AM and ethidium homodimer was assessed on 
cultures at 26 DIV (Figure 2.2A-C). Assessment with Hoechst 33342 and propidium 









Figure 2.1. Confirmation of the presence of all three cell types in 3-D multitypic neural 
cell cultures. Cultures were maintained for 13 DIV. (A,D,G) The neurons stain positively 
with MAP2, a marker for developing neurons. (B,E,H) The astrocytes stain positively for 
GFAP, an intermediate filament protein. (C,F,I) The microglia stain positively for Iba1, a 
calcium-associated protein that is expressed in macrophages and microglia. The low 
power images (A-C) give a broad view of the distribution of cells in the section of 
culture. Most of the positively-staining cells appear to be astrocytes and microglia as 
evidenced by the concentration of nuclear staining with GFAP and Iba1 labeling (D-F). 
The high power images (G-I) show the detail of the cellular morphology in the 3-D 














Figure 2.2. Cell viability assessment using two different methods. (A-C) A Live-Dead 
assay using Calcein AM  (A) and ethidium homodimer (B) to label viable and dead cells, 
respectively was performed on 3-D cultures (26 DIV). (C) A merged image of A and B. 
(D-F) Cell viability using Hoechst 33342 (D) and propidium iodide (E) to label the nuclei 
of all cells and dead cells, respectively was determined for 3-D cultures (21 DIV) . (F) A 




2.2D-F). In both cases, the cultures were rinsed with Dulbecco's phosphate-buffered 
saline (DPBS), exposed to the specified reagents (in DPBS) for 30 minutes and 
subsequently imaged using a Nikon Eclipse 80i upright microscope equipped with a 
MicroFIRE camera. Both methods showed a cell viability of approximately 90%. 
 Although these early assessments of the 3-D multitypic cultures were promising, 
there were a number of issues that needed to be optimized. First, the cultures would 
frequently retract and ultimately delaminate from the substrate after approximately one 
week. This could be attributed to either astrocyte contraction within the culture or some 
sort of astrocyte-mediated gel degradation. It was apparent that some astrocyte 
proliferation was occurring and that once a substantial portion of the cell population was 
astrocytic, the contraction of the cells would have a dominant effect on the gel geometry. 
Unpublished data supported this assertion as the problem of contraction was exacerbated 
with the inclusion of a higher proportion of astrocytes at the time of plating. Another 
priority in the development of the culture model was to find a way to improve microglial 
yield without the use of M-CSF. One of the goals of the culture system was for it to be 
responsive to inflammatory stimuli. The use of a treatment that induced the proliferation 
of microglia may have confounded attempts to induce inflammation experimentally as 
microglial proliferation occurs as a result of inflammation. Finally, the use of astrocytes 
after having maintained them between passages 4 and 10 became a concern. Although 
this resulted in a purer population, phenotypic drift is known to occur as cultured cells are 
maintained. Indeed, as the passage number increased, the astrocyte morphology was 
noticeably different and the proliferation rate decreased. Since other changes may occur 




were harvested became a design priority. In order to address these concerns, a number of 
modifications were made to the generation and maintenance of the 3-D multitypic 
cultures. 
2.3.2 Improved method: medium modification and the use of mixed glial cultures as a 
single source of all non-neuronal cells 
 The issue of gel retraction and delamination did not seem to affect the health of 
the cell culture as live-dead assessments were carried out on adherent and floating 
cultures with no significant variation in cell viability. However, processing adherent 
cultures for endpoint assays was far more expedient than if they were floating. 
Additionally, with the intention of subjecting the cultures to bulk mechanical injury in the 
future, having a culture that remained affixed to the substrate was necessary. As 
mentioned previously, the increased presence of astrocytes as the culture developed was 
assumed to be the source of the gel retraction. The medium formulation used throughout 
the maintenance of the 3-D cultures included G-5 supplement, which contains growth 
factors such as FGF and EGF among other components. As the supplement is designed to 
favor astrocyte growth in the absence of serum, its continued presence may have 
contributed to the gel retraction issue. It was decided that complete removal of the 
supplement was not logical as it may hinder the initial survival of the astrocytes 
following the trauma of trypsinization and 3-D plating. The cultures were initially plated 
and twice fed with G-5-containing medium. The subsequent feedings were with medium 
lacking G-5. All medium used for 3-D culture feedings was pre-warmed and pre-
conditioned with CO2 by placing an aliquot in a flask fitted with a filter cap into the 




volume, the cultures were weaned from G-5, rather than completely deprived of it. This 
modification to the culture protocol delayed gel retraction to two weeks. This is the time 
point to which the manufacturer tests gel stability at 37 ºC. No ill effects in terms of 
viability or cell development and morphology were observed as a result of weaning the 
cultures off of G-5. The potential effects of the absence of G-5 on the in vitro 
inflammation response are addressed further in Chapter 6. 
The concern about the method of inducing microglial proliferation was also 
ultimately addressed by changing a culture feeding procedure. It has been reported that 
frequent medium changes inhibits the proliferation of microglia [139]. The glia used to 
generate microglia for the 3-D cultures were fed every 2-3 days until the microglia were 
harvested. In an attempt to boost microglial yield without M-CSF treatment, the protocol 
was modified so that the mixed glial cultures were fed every 2-3 days until they reached 
confluence (~1 week). The subsequently unfed cultures were shaken to harvest microglia 
a week later. This method produced a microglial yield that was equal to, if not higher 
than, that obtained when using M-CSF treatment. As such, this became the standard 
method for generating microglia for the 3-D multitypic cultures. 
 The culture system was modified to limit the use of cells that had undergone 
multiple passages. The issue of using passaged astrocytes brings up a perennial debate 
about the validity of in vitro models in scientific research. While the population of cells is 
purer with passaging, the artificial selection and phenotypic changes that may occur 
during the cell culture process result in a subset of astrocytes which may be substantially 
functionally different from their primary progenitors. The flipside of this argument is that 




passaged cells may differ greatly from those in vivo, the consistency of a pure population 
of cells is conducive to more mechanistically-targeted experiments. Since the goal of this 
model was to mimic cortical tissue as closely as possible, passaged cells were no longer 
used. 
The culture method was modified to harvest both astrocytes and microglia from a 
single mixed glial culture. Since one of the main reasons for using passaged cells was to 
produce a pure astrocyte population, the presence of microglia in the early passage glial 
cultures had to be assessed. Estimation by visual inspection of the culture was 
confounded by the fact that microglia grow both loosely adhered on the surface of 
confluent astrocytes and to a lesser extent within the astrocyte layer. The former are 
easily identified as they are phase bright spheres on a lawn of phase dark cells whereas 
the latter are difficult to discern amid the surrounding astrocytes. It was determined that 
the best method for estimating the contribution of microglia from the astrocyte cultures 
would be to plate 3-D cultures consisting of neurons and early passage (two or fewer) 
astrocytes with and without additional microglia from the separate harvest. After 
immunolabeling the 3-D cultures for Iba1, it was qualitatively difficult to determine 
which cultures had been plated with additional microglia. This suggested that despite 
agitation and passaging, the astrocyte cultures still contained a substantial population of 
microglia. It was determined that rather than harvesting astrocytes and microglia from 
separate dissections and cultures, both cell types would be collected from the mixed glial 
cultures initially used for microglial harvest. Rather than shaking the cells for hours to 
enrich the medium with loosely adherent microglia, the cultures were trypsinized and 




only incorporated astrocytes at their first passage, it also greatly shortened the 
experimental lead time and simplified the culture process. 
Cultures generated using the new method were maintained for 11 DIV and 
processed for immunocytochemistry as described in the previous section. However, in 
lieu of cutting cryostat sections, the cultures were processed intact and imaged at low 
power using the same epifluorescence microscope setup as in the previous section. 
Cultures were labeled with a combination of MAP2 and GFAP or with Iba1. The 
immunolabeling reveals significant process extension of neurons and astrocytes (Figure 
2.3A-D). While the astrocytes appear somewhat clustered, the microglia are quite equally 
spaced and many are exhibiting process extension as well (Figure 2.3E-G). 
These changes in medium composition, feeding schedule, and cell harvest 
protocol resulted in cultures that could be plated and ready for experimentation (14 DIV) 
in less than a month. Additionally, much less tissue and fewer cell culture materials were 
required for production. While these were certainly not the last modifications made to the 
3-D culture protocol, this streamlined process provided a sound foundation for 3-D 
culture experimentation. Later chapters will explore further improvements to the culture 
system ranging from the development of custom chambers to the use of a more defined 
medium composition. 
2.4 Conclusions 
 This chapter has detailed the incremental development of a novel in vitro 
representation of rat cortical tissue. This 3-D multitypic neural culture model began as an 
expansion of previously described methods to incorporate an underrepresented cell type. 










Figure 2.3. 3-D multitypic neural cell cultures contain neurons, astrocytes, and microglia 
with healthy morphology. 3-D cultures (11DIV) were incubated with antibodies against 
MAP-2 to label neurons (A) and GFAP to label astrocytes (B) as well as with a Hoechst 
nuclear counterstain (C). (D) A merged image of A, B, and C. Separate cultures were 
incubated with an antibody against Iba1 to label microglia (E) and also counterstained 




be more challenging than anticipated in terms of obtaining sufficient yield so that the 
microglial population would reflect that of the in vivo model. In the process of 
developing this culture system, modifications were made to earlier methods such that all 
cells used would be closer to the primary state rather than being a blend of primary and 
secondary cells. Specifically, the mixed glial cultures undergo a single passage at the 
time of plating when they are combined with primary neurons to generate the final 3-D 
cultures. Further adjustments to maintenance medium protocols resulted in more stable, 
adherent gels at 14 DIV. This proved to be critical in the characterization of 
inflammatory response of these cultures.  
Although the increased complexity gained through the addition of microglia 
brings the 3-D culture model closer to what can be achieved using an in vivo model, it 
clearly remains far removed from living tissue. This is perhaps the greatest weakness of 
in vitro research. Many may argue that in the absence of vasculature a complete picture 
of the inflammatory response to injury cannot be represented. This is true. However, this 
next generation of 3-D neural culture is simply another step toward creating an ideal in 
vitro model of brain tissue. Despite the absence of many of the key players involved in 
the injury response, much can learned about isolated cellular behaviors. The distinct 
advantage afforded by this system is control. By creating homogeneous primary cultures 
with tissue from multiple animals, variability is reduced, and some subtle effects which 
may be lost in statistical noise in vivo may be elucidated. This is not to suggest that the 
model presented here should be implemented in lieu of in vivo models. Rather, just as 
animal models are used as a precursor to clinical research, so too can in vitro systems 




neural cell culture system could further be augmented by the introduction of more cell 
types. However, characterization of the system as developed here provides insight into 





CHARACTERIZATION OF THE 3-D MULTITYPIC NEURAL CELL CULTURE 
SYSTEM AS A MODEL OF NEUROINFLAMMATION 
3.1 Introduction 
 The driving force behind developing the 3-D multitypic neural cell culture system 
was ultimately to use it to study the neuroinflammatory responses induced by injury. 
Although neurons and particularly astrocytes can participate in inflammatory signaling 
cascades, the main cells that fill this role are microglia. Incorporating these cells into the 
culture system was a critical step in creating an in vitro model of neuroinflammation. As 
research in the area of neuroinflammation has progressed, it has become clear that 
inflammation plays a key role in the secondary and long-term responses to a number of 
neurological insults. As such, it is a prime target for therapeutic intervention. However, 
inflammation has both ameliorative and deleterious effects, and it is this duality that 
makes understanding its underlying mechanisms so crucial. No pre-clinical studies for 
therapeutic intervention following TBI have successfully translated to humans. Using an 
in vitro neuroinflammation model as the basis for therapeutic research may clarify new 
avenues of study that lead to successful treatments. 
Since the study of microglia began almost a century ago, a great deal has been 
learned about their function. There exist many protocols for their isolation and 
maintenance in vitro [76, 128, 129, 140, 141], but their use in the unique system 
presented here requires that their growth and behavior be characterized in this new 
milieu. As discussed in Chapter 1, microglia can exist in at least two different functional 




state. Although they extend processes and can be activated, microglia in vitro do not 
exhibit the ramified phenotype associated with “resting” microglia in vivo [96, 146].  
They do, however, extend processes and morphological changes toward a more rounded 
phenotype can be induced with LPS treatment [147]. Ideally, the cells plated into the 3-D 
cultures will initially grow as quiescent cells and be inducible into an activated state in 
response to insult. In tandem with the incorporation of microglia into the 3-D multitypic 
neural cell culture model, some isolated microglia were maintained in 2-D in order to get 
a sense of their behavioral characteristics (morphology, proliferative capacity, etc). 
Visualization of microglia in 2-D cultures can more easily be achieved than in 3-D 
cultures as there is no interference from multiple cellular layers. When plated into fresh 
flasks after isolation from the mixed glial cultures, the microglia adhered to the uncoated 
tissue culture plastic within minutes. At this point, they exhibited a rounded morphology. 
When maintained in the same serum-containing medium in which the mixed glia were 
grown, they did not noticeably change or proliferate over the course of a week, even 
when exposed to M-CSF. Rather, after a week they would shrink and ultimately die. 
However, when the serum was replaced with G-5, the microglia began to extend 
processes after 2-3 days. They still did not proliferate, even with M-CSF exposure. Given 
these observations, clear critical factors to consider in developing an in vitro model of 
neuroinflammation were that microglia would only proliferate in the presence of 
astrocytes and that the use of G-5 was preferable to serum to induce process extension. In 
the culture model presented in Chapter 2, the microglia are generated from mixed glial 




environment. This design meets the criteria, making the method for 3-D multitypic neural 
cultures a candidate for a neuroinflammation model. 
 Prior to any mechanical injury testing (Chapter 4), the system was characterized 
using LPS as a positive control for inflammation. It was expected that exposing the 
cultures to LPS would induce a broad inflammatory response detectable by many 
different outcome measures. The expected outcome was for the LPS stimulation to cause: 
cytokine release, upregulation of inflammatory molecules at the mRNA and protein level, 
nitric oxide release, generation of ROS, morphological changes in the microglia from an 
inactive to an active state, and possibly cell death. An induced inflammatory response 
would be the first step in validating the 3-D multitypic neural cell culture system as a 
model of neuroinflammation. 
3.2 LPS-induced neuroinflammation 
3.2.1 LPS as a positive control 
 The gram-negative bacteria surface molecule, LPS is known to stimulate the 
innate immune response across many species [148-150]. It binds to toll-like receptor 4 
(TLR4), a highly conserved molecule expressed on the surface of macrophages and 
dendritic cells. Along with CD14, TLR4 mediates the inflammatory response to LPS, in 
particular, the release of cytokines such as the pro-inflammatory IL-1β. As microglia are 
derived from a dendritic cell lineage, they are stimulated by LPS through the same TLR4-
mediated pathway. Since cytokines such as IL-1β are also released by microglia in 
response to traumatic injury, stimulation of these cells with LPS was used to demonstrate 
that the cells could be potentiated into a state of inflammation. It therefore represents a 




utilized with each of the outcomes measures to be used in mechanical injury experiments 
to confirm the inflammatory potential of the model. 
3.2.2 General experimental methods 
 3-D multitypic neural cell cultures were generated as discussed in Chapter 2 and 
as described in detail in Appendix A. All data presented in this chapter were acquired 
from 3-D cultures grown in reusable, custom-made culture chambers described in Section 
4.2.2. Cells were generally maintained in a 37 ºC incubator at 5% CO2 and 95% relative 
humidity for either 7 or 14 days prior to LPS stimulation, although other time points were 
sometimes used where indicated. LPS (Sigma-Aldrich) was delivered as part of a 
complete medium change. 3-D cultures were exposed to medium containing LPS at either 
a concentration of 10 μg/mL or at a higher concentration to compensate for the dead 
volume of the culture (as the primary constituent of the hydrogel is water). The latter is 
indicated as a “final” LPS concentration of 10 μg/mL.  
For experiments in which released factors were being measured, conditioned 
medium was collected at time points ranging from 1 to 24 hours. For outcome measures 
requiring cellular material, the gels were degraded using BD™ Cell Recovery Solution 
(BD Biosciences, San Jose, CA) according to the manufacturer’s protocol. Live cell 
imaging for NO was carried out in situ using an NO-sensitive dye diluted in DPBS. Cells 
processed for immunocytochemistry were fixed with 2% paraformaldehyde in phosphate-
buffered saline (PBS), permeabilized with 0.1% Triton X-100, incubated with primary 
antibody overnight at 4 ºC and with secondary antibody for 1-2 hours at room 
temperature. All solutions for immunolabeling (including rinse buffer) contained 0.05% 




fluorescent markers as discussed in Chapter 2 or by the use of a lactate dehydrogenase 
(LDH)-based In Vitro Toxicology Assay Kit (Sigma-Aldrich). Methods pertinent to 
individual experiments are detailed in the subsequent sections. 
3.2.3 Changes in cytokine mRNA levels 
 Levels of mRNA expression were measured via microarray following treatment 
of cultures with LPS. After 14 DIV, 3-D neural cultures were treated with LPS at a final 
concentration of 10μg/mL (n=6) or with Hank's balanced salt solution (HBSS) vehicle 
(n=6) for 4 hours. This time point was chosen as both mRNA [88] and protein 
concentrations [73] of a number of cytokines have been shown to be elevated at 4 hours. 
The Matrigel™ matrix was degraded by treating the cultures with BD™ Cell Recovery 
Solution for 2 hours on ice with agitation on an orbital shaker. Two cultures were pooled 
to represent a single sample (pooled n=3). The sample pooling was determined in 
preliminary experiments to be necessary to generate enough RNA for the microarrays. 
Total RNA was extracted with TRIzol Reagent (Life Technologies), quality 
controlled, and quantified by Agilent 2100 Bioanalyzer (Agilent Technologies, Santa 
Clara, CA). Microarrays were completed according to manufacturing guidelines 
(Affymetrix® Inc., Santa Clara, CA), with cRNA hybridized to an Affymetrix Rat 
Genome 1.0 ST GeneChip® array (Affymetrix Inc.). The chips were hybridized at 45°C 
for 16 hours, washed, stained with streptavidin-phycoerythrin, and scanned according to 
manufacturing guidelines. Three chips were used for each experimental group: with and 
without LPS treatment. Table 3.1 shows some of the notable species that had a 
significantly (ANOVA) elevated message level, namely cytokine iNOS and the 















Levels of mRNA expression of pro-inflammatory molecules are elevated in 3-D 
multitypic neural cell cultures in response to LPS stimulation. Cultures (14 DIV) were 
exposed to a final concentration of 10 μg/mL LPS or to HBSS vehicle for 4 hours. The 
matrix was disintegrated to isolate the cells and the RNA was extracted from the cells 
using TRIzol Reagent. Microarrays (Affymetrix Rat Genome 1.0 ST GeneChip®) were 
completed and the data were statistically analyzed by ANOVA (without LPS, n=3; with 
LPS, n=5). LPS treatment produces a significant increase in the levels of many 
molecules. Those presented in the table are representative of the molecules expected to 





are chemically inducible to an inflammatory state. However, an increase in gene 
transcription does not always correlate to an increase in translation into protein. As such, 
the next step was to assess cytokine production at the protein level. 
3.2.4 Effects on IL-1β protein levels 
 Based on the microarray data as well as the known mechanistic relationship 
between LPS exposure and IL-1β release, this cytokine was chosen for outcome testing at 
the protein level. Prior to release from the cell, a pool of immature IL-1β is present near 
the cell surface, ready for rapid signaling. Upon insult, the immature molecule is cleaved 
into its mature form by caspase-1 and is released from the cell to deliver its pro-
inflammatory signal. Assuming this mechanism is present and functional in this culture 
system, it was expected that mature IL-1β would be detectable by ELISA in the culture 
medium in response to LPS stimulation. The microarray data demonstrated that the levels 
of IL-1β mRNA were increased in response to LPS stimulation. It was expected that this 
elevation would correspond to an increase of intracellular IL-1β protein levels upon LPS 
stimulation as detected by Western blot and immunocytochemistry. 
3.2.4.1 LPS-induced IL-1β release 
 After 7 DIV, 3-D cultures were exposed to normal medium or to medium 
containing 10 μg/mL LPS. The medium was collected 24 hours later and centrifuged at 
1,000 rcf to remove any contaminating cells. The supernatant was collected (n=3 per 
condition) and analyzed with a rat IL-1β ELISA kit (R&D Systems, Minneapolis, MN). It 
is clear that after 24 hours of LPS exposure, the concentration of IL-1β in the medium is 
substantially higher than that in the medium of untreated cultures (Figure 3.1). The means 






























Figure 3.1. 3-D multitypic neural cell cultures release IL-1β in response to LPS 
stimulation. Cultures (7 DIV) were exposed to 10 μg/mL LPS or to HBSS vehicle for 24 
hours. The medium was collected and assayed for IL-1β by ELISA. LPS treatment 
produces a significant increase in the levels of IL-1β (p<0.01, n=3) Data were statistically 
compared using a one-tailed, unpaired t-test with Welch’s correction for unequal 





for unequal variances (p<0.01). The correction was applied after the variances were 
determined to be significantly different using an F-test. Despite the small sample size, 
these data indicate that the 3-D cultures can be induced to produce a characteristic 
inflammatory response upon exposure to the LPS positive control.  
3.2.4.2 LPS-induced upregulation of IL-1β protein expression 
 Following the quantitative analysis of released IL-1β by ELISA, the question 
remained as to whether LPS stimulation caused a concomitant upregulation of 
intracellular protein expression. To address this, both Western blot and 
immunocytochemistry methods were employed. At 13 DIV, 3-D cultures were given 
normal medium containing HBSS vehicle (n=3) or medium containing 10 μg/mL LPS 
(n=3). After 4 hours, cultures from each experimental condition were rinsed with cold 
PBS containing a “cOmplete” protease inhibitor cocktail (PIC) (Roche Life Science, 
Indianapolis, IN), collected with BD™ Cell Recovery Solution containing PIC, and 
pooled into Eppendorf tubes (pooled n=1 per condition). As with the sample preparation 
for the microarrays, sample pooling was necessary to ensure sufficient protein for loading 
the SDS-PAGE gel. The tubes were kept on ice for one hour with frequent inversion to 
facilitate the disintegration of the gel. The samples were centrifuged at 1,000 rcf at 4 ºC 
for 5 minutes and the pellets were resuspended with a protein extraction solution 
containing NP-40, deoxycholate, and PIC. The tubes were kept on ice and vortexed 
periodically during protein extraction. The samples were centrifuged at 1,000 rcf at 4 ºC 
for 5 minutes and the supernatants were transferred to clean Eppendorf tubes. Protein 
content was determined by BCA protein assay (Pierce™/Life Technologies) and the 




buffer. The reduced and denatured samples were separated in 8-16% Tris-Glycine 
gradient SDS-PAGE gels (Invitrogen™/Life Technologies) and wet-transferred to PVDF 
membrane (EMD Millipore, Billerica, MA) for antibody detection. The membrane was 
exposed to anti-rat IL-1β antibody (R&D Systems) overnight at 4 ºC. The membrane was 
incubated with secondary antibody conjugated to IR Dye 800 (Rockland 
Immunochemicals Inc., Pottstown, PA) and scanned using an Odyssey® infrared scanner 
(LiCor, Lincoln, NE). 
 The Western blot data reveal a clear upregulation of intracellular IL-1β protein 
(Figure 3.2). The immature form of the cytokine is expected to migrate at an apparent 
molecular weight of 31 kD, while the mature form is expected at 17 kD. The immature 
form is clearly detectable in the untreated sample, but the mature form is not. LPS 
stimulation causes a large increase in intensity of the band representing immature IL-1β 
and makes the band representing the mature form detectable. The weaker band migrating 
slightly higher than 31 kD likely represents a posttranslationally modified (e.g. 
glycosylated) form of IL-1β. Even with LPS exposure, the mature IL-1β band is fairly 
weak. This is likely due to the release of this form from the cell in response to the insult. 
These data reveal that treatment with LPS causes a substantial increase in intracellular 
levels of IL-1β after only a 4 hour exposure. 
 To visualize the expression of IL-1β in response to LPS stimulation, 3-D cultures 
maintained for 21 DIV were exposed to LPS at a final concentration of 10 μg/mL or to 
medium containing and equivalent amount of HBSS vehicle for 24 hours. The cultures 
were subsequently fixed with paraformaldehyde and processed for immunocytochemistry 



















Figure 3.2. Intracellular levels of IL-1β are upregulated in response to LPS stimulation. 
Cultures (13 DIV) were exposed to 10 μg/mL LPS (n=3, pooled n=1) or to HBSS vehicle 
(n=3, pooled n=1) for 4 hours. At 4 hours post-injury, Western blot data indicates there is 
a substantial upregulation of the intracellular production of IL-1β. The 31 kD band 
represents the immature form of IL-1β. LPS stimulation induces the production of a small 
amount of mature IL-1β present which is indicated by the 17 kD arrow. The latter was 




Western blotting. Fluorescent images were captured using the same epifluorescence 
microscope and camera setup described in Section 2.3.1. The vehicle-treated cultures 
show only low-intensity, fibrillar labeling that is likely nonspecific (Figure 3.3A,B). 
When treated with LPS, however, the signal is much more intense and is present in cells 
with morphology that is characteristic of microglia (Figure 3.3C,D). Based on the 
Western blotting data, it is likely that the observed signal increase is due to the 
upregulation of immature IL-1β in the cells. The immunocytochemistry data suggest that 
microglia are the primary contributors to the LPS-driven IL-1β response in the 3-D 
cultures. 
3.2.5 Effect on NO production 
 Along with the increased levels of cytokine mRNA determined by microarray as 
presented in Section 3.2.3, the mRNA level of iNOS was also increased. Thus, it was 
expected that stimulation with LPS would produce a detectable increase in NO levels in 
the culture medium. NO is a toxic free radical generated in response to pro-inflammatory 
cytokines released in response to an insult. As is the case with any free radical species, 
the molecule is unstable and thus, difficult to detect experimentally. Thus, levels of NO 
are most often determined by assaying for nitrite, a stable breakdown product of NO. 
Developed in 1858, the Griess test is a simple, commonly used colorimetric method for 
the determination of nitrite in biological fluids and cell culture media. Additionally, in 
order to directly determine the level of NO production in response to LPS stimulation, a 











Figure 3.3. Immunocytochemical visualization of LPS-induced IL-1β expression. 
Cultures (21 DIV) were exposed to a final concentration of 10 μg/mL LPS or to HBSS 
vehicle for 24 hours. Fixed cultures were incubated with antibody against IL-1β as well 
as with a Hoechst nuclear counterstain. (A) IL-1β labeling in vehicle-treated cultures 
appears nonspecific and fibrillar. (B) IL-1β in vehicle-treated cultures with nuclear 
counterstain. (C) IL1β in LPS-treated cultures labels cells with morphology consistent 





After 11 DIV, 3-D cultures were exposed to LPS at a final concentration of 10 
μg/mL (n=3) or to HBSS vehicle (n=3) for 24 hours. The cultures were rinsed with DPBS 
and subsequently exposed to the NO-sensitive hydrocyanine dye for one hour. Three of 
the cultures for each condition were rinsed with DPBS and imaged using an IVIS 
Lumina® near-infrared imaging system (PerkinElmer, Waltham, MA). The raw data from 
the in situ labeling with the infrared NO sensor dye showed an increase in fluorescent 
signal after LPS stimulation (Figure 3.4A). This difference was determined to be 
statistically significant by an unpaired t-test using Welch’s correction for unequal 
variances (p<0.01) (Figure 3.4B). After 7 DIV, similar cultures were exposed to medium 
containing 10 μg/mL LPS or to HBSS vehicle. The media from three samples per 
condition was collected at 24 hours and the level of nitrite present was determined using 
a Griess assay (Promega, Madison, WI). Without LPS stimulation, there is no detectable 
nitrite in the culture medium as the signal from the Griess assay is outside the range of 
the standard curve. The presence of LPS caused nitrite levels to elevate to an average of 
nearly 6 ng/mL after 24 hours (Figure 3.4C). Although it is a bit misleading to run a 
statistical analysis on these data as it is essentially comparing a detectable signal to the 
absence of a signal, the means are significantly different as determined by an unpaired t-
test using Welch’s correction for unequal variances (p<0.01). Thus, the in situ NO data 
and the measure of nitrite from separate cultures are in agreement that LPS exposure 
increases levels of NO in the cultures. 
3.2.6 Effect on 3-D culture viability 
 LPS stimulation failed to induce process retraction or any morphological change 











Figure 3.4. 3-D multitypic neural cell cultures release NO in response to LPS 
stimulation. (A) Cultures (11 DIV) exposed to a final concentration of 10 μg/mL LPS for 
24 hours show an increased fluorescence signal using an NO-sensitive infrared dye. (B) 
Quantification of this signal reveals a significant difference in the level of NO (p<0.001, 
n=3). (C) Medium collected from cultures (7 DIV) treated with the same conditions 
contains significantly higher levels of nitrite at 24 hours (p<0.01, n=3). Data were 




microglial activation in response to LPS would ultimately be toxic to the cultures as was 
expected based, in particular, on the induced NO release [152-155]. To determine the 
effect of LPS on culture health, cell viability was assessed by both fluorescent live-dead 
assay and by measuring LDH release. As described in Section 2.3.1, two methods of 
determining cell viability by fluorescence were implemented. The first, a “live-dead” 
assessment using calcein AM and ethidium homodimer to label live and dead cells, 
respectively, was performed 24 hours after cultures (25 DIV) were subjected to 10 μg/mL 
LPS stimulation (n=4) or to a medium change (n=2). The results showed that LPS 
induced a small, but statistically significant reduction in cell viability in the cultures 
(p<0.05) (Figure 3.5A). However, a subsequent experiment in which Hoechst 33342 and 
propidium iodide were used to label the nuclei of all cells and dead cells, respectively, 
was performed 48 hours after cultures (19 DIV) were subjected to 10 μg/mL LPS 
stimulation (n=4) or to a medium change (n=4) as before. The results did not reveal any 
difference in cell viability due to LPS exposure (Figure 3.5B). 
The fact that the two methods yielded different results can be attributed to the 
method of cell count determination. As described in Section 2.3.1, this was achieved by 
thresholding the images and determining counts by defining cell geometry parameters. 
Since epifluorescent images of intact 3-D cultures were captured, signal from multiple 
focal layers was detected. As calcein causes the entire cellular cytoplasm to fluoresce, 
determining cell boundaries was challenging despite the use of a broad range of threshold 
levels. As a result, multiple cells may have been counted as a single cell. Thus, the 
number of viable cells using this method may have been underrepresented, and given the 














Figure 3.5. Determination of cell viability in response to LPS stimulation using 
fluorescent markers. (A) 24 hours after cultures (25 DIV) were exposed to 10 μg/mL LPS 
(n=4) or to HBSS vehicle (n=2), a Live-Dead assay was performed using Calcein AM 
and ethidium homodimer to label viable and dead cells, respectively. LPS treatment 
significantly reduces cell viability (p<0.05). (B) 48 hours after cultures (19 DIV) were 
exposed to 10 μg/mL LPS (n=4) or to HBSS vehicle (n=4) viability was assessed using 
Hoechst 33342 and propidium iodide to label the nuclei of all cells and dead cells, 
respectively. This method shows no significant difference between the naïve cultures and 
the LPS-treated cultures. Data were statistically compared using a one-tailed, unpaired t-




the primary reason that the second method exclusively using nuclear stains was 
employed. It was expected that sequestration of signal to the nucleus would improve the 
ability to accurately separate individual cells. Indeed, the total cell count using this 
method was higher using the same experimental conditions. Although this appeared to be 
more consistent, the presence of clustered and overlapping cells still posed a problem for 
acquiring accurate cell counts. Thus, cell death was next assessed by measuring LDH 
release in response to LPS exposure. 
LDH is an enzyme that is broadly expressed in the cells of nearly all organisms. It 
reversibly catalyzes the conversion between pyruvate and lactate in the glycolysis 
pathway. Due to its ubiquity and high expression level, it is an easily detected marker for 
cell damage and its release is often used as an indicator of cell death. 3-D cultures 
maintained for 13 DIV were exposed to medium containing 10 μg/mL LPS (n=6) or to 
normal medium (n=2) for 23 hours. At this point, the medium was collected and LDH 
was measured colorimetrically using an In Vitro Toxicology Assay Kit. The acquired 
data were compared to that from cultures given normal medium and treated with 0.1% 
Triton X-100 for 1 hour prior to media collection. The permeabilization of all cell 
membranes with this detergent gives data that represents maximum LDH release. The 
data show that LPS has no significant effect on the viability of the cells (Figure 3.6). 
These data corroborate that obtained from the viability assessment using the nuclear 
markers. The lack of LPS-induced toxicity was a surprise given the expectations based on 
the effects of LPS on cytokine levels in the 3-D cultures. Coupled with the lack of 
morphological changes in the microglia, these data certainly call into question the parity 



































Figure 3.6. Determination of cell viability in response to LPS stimulation by LDH 
release. 23 hours after cultures (13 DIV) were exposed to 10 μg/mL LPS (n=6) or to 
HBSS vehicle (n=2), LDH levels in the medium were determined using an In Vitro 
Toxicology Assay Kit. No significant difference in cell viability is evident using this 
method. Data were statistically compared using a one-tailed, unpaired t-test. Bars are 




LPS as expected in terms of cytokine expression and release, the 3-D multitypic neural 
cell cultures certainly have viable uses for in vitro research. 
3.3 Culture system applications 
 The added layer of complexity introduced to these cultures by the incorporation of 
microglia provides a platform on which in vitro inflammation studies can be based. 
Whereas previously studied culture systems have included two of the three cell types 
present here, they lacked the more complete picture of cellular interaction offered by this 
system. The fact that the microglia are inducible into an inflammatory state demonstrates 
that these cultures could be used in the study of any disease in which inflammation plays 
a role. The ever-increasing body of research into this topic has revealed that this spectrum 
of disorders is expanding. Inflammatory processes are continually being implicated in the 
development and exacerbation of disease states affecting cells throughout the human 
nervous system, including AD, Parkinson’s disease, multiple sclerosis, and amyotrophic 
lateral sclerosis [156, 157]. This system models cortical neural tissue and is thus 
applicable to the study of diseases in which these cell populations are particularly 
vulnerable such as AD. Presumably, this culture system would be a viable candidate for 
studying both pro-inflammatory and anti-inflammatory mechanisms that occur in disease. 
One field of study in which such mechanisms are of particular interest is TBI. The 
neuron-astrocyte co-cultures previously described by our lab were indeed designed and 
used for TBI experiments. The utilization of 3-D cultures allows for mechanical loading 
that is closer to what occurs in vivo. The implementation of this culture system in 




 In the same vein as traumatic injury, the 3-D multitypic neural culture system 
could also be used to study the inflammatory effects of foreign bodies in CNS tissue. This 
would be appropriate for the optimization of electrode or device implantation in which 
limiting the host response is a major concern. Brain injury resulting from stroke or 
aneurysm could be modeled by incorporating this culture system into hypoxia and anoxia 
studies. Blast injury could also potentially be modeled using this system and is discussed 
further in Chapter 6. Finally, given that the cells used in these cultures are from early 
stages of development, diseases such as fetal alcohol syndrome or other maladies 
stemming from drug exposure in utero could effectively be modeled. The true strength of 
an in vitro model of neuroinflammation is that once the baseline response to the insult of 
choice has been established, methods of clinical intervention to enhance neuronal 
survival can readily be tested. Further, by scaling up the number of cultures generated in 
a particular experiment, high-throughput studies could also be carried out. This 3-D 
culture system has the potential to provide the foundation of powerful in vitro disease 
models in which inflammation-mediated secondary injury mechanisms can be studied. 
3.4 Conclusions 
 This chapter has provided support to the assertion that the 3-D multitypic neural 
culture model is a viable model of neuroinflammation. Multiple studies in which an 
inflammatory response was induced revealed that cytokine expression at both the mRNA 
(microarray) and protein (ELISA, Western blot, and immunocytochemistry) level are 
increased in response to LPS. Further, the release of NO as measured both directly 
(infrared dye imaging) and indirectly (nitrite levels) was demonstrated, which suggests 




However, this was not corroborated by cell viability and LDH release studies. Also 
concerning was the lack of a morphological shift in the microglia in response to LPS 
which has been reported to be accompanied by increased NO production [152, 158]. It 
was expected that this shift would occur as it precedes microglial migration and 
proliferation in response to an inflammatory stimulus in vivo. However, this 
morphological change is not directly caused by LPS. Rather, signaling molecules such as 
ATP may be absent due to the lack of LPS cytotoxicity. Despite the absence of these 
responses to LPS stimulation, it can be argued that this system still represents a valid 
model as the cultures exhibit a cytokine expression profile consistent with 
neuroinflammation. 
 Aside from the lack of cytotoxicity, comparison with other in vitro models of 
LPS-induced neuroinflammation shows parity with the system presented here. Treatment 
of primary rat microglia with LPS has been shown to elevate levels of nitrite in the 
culture medium at 24 hours [159, 160] as well as to increase levels of TNF-α, IL-1β, and 
IL-6 within the same time frame [160]. Treatment with a combination of LPS and IFN-γ 
has also been shown to elevate levels of nitrite at 24 hours for both primary rat microglia 
and BV-2 cells [91]. In a cerebellar granule cell neuron-glia co-culture model, treatment 
with LPS/IFN-γ resulted in an increase in nitrite after 48 hours [87]. The model that most 
closely relates to that presented here is the aggregating neural cell culture model. This 
culture method generates spheroids composed of multiple cell types that can be 
maintained as a 3-D aggregate supported by ECM derived from the primary cells. 
Aggregating spheroids derived from E16 rats treated with LPS/IFN-γ for 24 hours 




PCR [161]. The elevation of pro-inflammatory species at the mRNA and protein level as 
well as the increase in NO production as measured by nitrite levels corresponds well to 
the data acquired using the system described here. Although IFN-γ was never included 
with LPS stimulation, its use has been described as a means to augment the LPS response 
[162]. As such, it is reasonable to compare these models with the 3-D multitypic neural 
cell culture model. Where this system differs is in the lack of LPS-induced morphological 
changes in microglia [146] and in the absence of cytotoxicity. Decreased neuronal 
viability in response to LPS treatment has been described in transwell insert-separated 
and direct co-cultures of primary rat neurons and microglia [163]. Additionally, neuronal 
cell death in response to LPS/IFN-γ has been shown in cerebellar granule cell neuron-glia 
co-cultures enriched with microglia [87] and in co-cultures of primary mouse neurons 
with either primary mouse microglia or BV-2 cells [91]. Thus, although this model 
exhibits many of the expected responses to LPS stimulation, it does not demonstrate 
decreased cell viability. 
There are a number of possible explanations as to why the expected increase in 
cell death was not observed. First, the cultures may simply not have been incubated with 
LPS long enough for the neurotoxic mechanisms to initiate. The longest time point prior 
to medium collection post LPS exposure was 24 hours. It is possible that extending the 
exposure beyond this time point may elicit the expected cell toxicity. Second, the 
concentration of LPS used for these experiments was quite high. Since this stimulation 
induces a broad innate immunity response from the microglia consisting of the release of 
many different cytokines, the cultures may have been overwhelmed to the point that no 




neuroprotective pathways may have been concomitantly activated, effectively resulting in 
offsetting mechanisms. Specifically, this system differs from most of those discussed 
previously due to its inclusion of astrocytes. Astrocytes can be neuroprotective as they 
have mechanisms to alleviate oxidative stress [164]. However, they have also been 
demonstrated to have neurotoxic effects in response to LPS stimulation in vitro [165]. 
Whether their presence in this system is helpful or harmful cannot readily be determined, 
but their potentially ameliorative effect cannot be ruled out. 
A final possibility for the lack of cell death is that some technical aspects of the 
culture method may be unfavorable to the initiation of neurotoxic signaling cascades. The 
cell density of the 3-D cultures (4,000 cells/mm3) is high relative to typical 2-D plating 
densities (50,000-100,000 cells/cm2)—the 2-D density equivalent of these cultures if the 
same number of cells were plated would be 400,000 cells/cm2. Despite the increased cell 
density afforded by the 3-D geometry, the cultures still have densities that are more than 
an order of magnitude lower than the in vivo rat cortex [166]. The resulting intercellular 
distances in these cultures are relatively large and released cytokines may diffuse in such 
a way that no gradients can effectively be established. Additionally, the 3-D gel is 
covered with a volume of feeding medium which is more permissive to diffusion than the 
gel itself. Therefore, cytokine density is further diluted, perhaps preventing the expected 
signaling. Indeed, each of the cytokine-based outcome measures presented in this chapter 
detects output from cells in direct response to the LPS stimulation. Induction of cell death 
would require intercellular signaling as microglia are the primary effectors of the LPS 




The absence of a morphological shift in response to LPS can be explained with 
similar reasoning. The TLR4-mediated innate immune response mounted by the 
microglia upon LPS stimulation is, again, a broad response in the sense that many 
cytokines are upregulated and released. As with the explanation for lack of cell death, 
signaling molecules that would induce a morphological change may be effectively diluted 
to the point that their signals are not transmitted. Alternatively, the composition of the 
Matrigel™ ECM may be affecting the microglial response. This will be explored further 
in later chapters. The lack of cell death itself may be the reason that the shift is not 
observed. Many of the mechanical aspects of microglial behavior, including 
morphological shift and chemotaxis, rely on ATP gradients which typically result from 
dying cells. In the absence of dying cells or exogenous ATP, the cultures may lack the 
necessary signals to induce microglia to assume a rounded morphology. This brings up 
the question of the efficacy and validity of LPS as a positive control for 
neuroinflammation in this system. 
 In subsequent chapters, the 3-D multitypic neural cultures are subjected to 
various mechanical insults with the intent of modeling the secondary injury mechanisms 
associated with TBI. In order to assess the ability of the cultures to be induced into a state 
of inflammation, LPS was chosen as a positive control as it has classically been used to 
induce inflammation in both in vivo and in vitro models [167]. However, given that the 
TLR4-mediated inflammation pathway activated by LPS is part of the innate immune 
response, it is perhaps not the best control for a TBI model. Although microglia are 
certainly activated in response to injury in vivo [65, 125, 126], the mechanisms by which 




quiescent to an active state are different than those of innate immunity. Additionally, LPS 
has been described as an “incomplete stimulus” that requires another factor such as ATP 
since LPS generates a large pool of intracellular immature IL-1β, but is less effective at 
inducing cleavage and release [77].  
The presence of ATP from dead or dying cells is crucial for the activation of 
microglia signaling pathways. This signaling occurs through purinergic receptors on the 
microglial cell surface. This large family of receptors includes ionotropic and 
metabotropic members which have been shown to be responsible for cellular responses 
ranging from chemotaxis [133, 168] to induction of IL-1β release [131]. The latter is 
associated with activation of the P2X7 purinergic receptor by ATP [79]. Based on this 
information, stimulation of the 3-D cultures with ATP would likely be a more relevant 
positive control for the injury mechanisms associated with TBI. The introduction of a 
modified form of ATP to these cultures is explored further in Chapter 6. However, LPS 
stimulation demonstrated that the microglia in these cultures can be induced into a state 
of inflammation which was the primary goal of these experiments. The next step of the 
research presented here is to develop a mechanical injury protocol for these cultures that 





IMPLEMENTATION OF THE 3-D MULTITYPIC NEURAL CELL CULTURE 
SYSTEM IN THE DEVELOPMENT OF A MECHANICAL INJURY MODEL OF 
TRAUMATIC BRAIN INJURY 
4.1 Introduction 
  The development of an in vitro model of TBI requires a system in which the 
mechanical deformations that occur in vivo can be mimicked. Mechanical injury of 
cultured cells has long been studied in 2-D using methods such as scratching cells on a 
rigid substrate and stretching cells on a flexible membrane. The former method lacks 
consistency, but the latter has been successful with slice cultures [41] in addition to 2-D 
cultures [46, 169]. In our lab, delivery of the mechanical load that produces the stretch 
injury is achieved using a circular tube piston driven by a linear actuator at specified 
velocities and displacements to achieve the desired strains and strain rates. While injuries 
carried out in this manner can reproduce some of the forces experienced by cells in TBI 
in vivo, the 2-D geometry of the culture system certainly affects the subsequent cellular 
response. Such studies are effective for modeling the acute effects of injury, but may not 
adequately represent secondary injury mechanisms. In our lab, these experiments at most 
included neurons and astrocytes. As discussed in Chapter 2, were microglia to be 
included in a 2-D culture system, many of them would grow as rounded cells, loosely 
adhered to astrocytes. As such, the microglia would not experience the same strain as the 
neurons and astrocytes which would be in direct contact with the flexible membrane. 
Using a 3-D culture system results in a more “tissue-like” environment in which all of the 




when mechanically injured. As previously discussed, the 3-D cultures described in 
Section 2.2 have been extensively utilized in both shear and compression injury studies. 
 In the initial development of a mechanical injury model using the 3-D multitypic 
neural cultures, a similar approach was used as with the development of the cultures 
themselves. Specifically, previously defined injury methods were implemented wherein 
3-D cultures containing neurons, astrocytes, and microglia were used in place of the 
neuron-astrocyte co-cultures. The first goal was to confirm that the new cultures could be 
injured in a manner that yielded a consistent level of cell death in the cultures. Since the 
ultimate goal of this research was to create a model of mechanically-induced 
neuroinflammation, the establishment of a method that resulted in the death of a 
significant population of cells without killing the entire culture was critical. Too mild an 
injury might not be sufficient to trigger an inflammatory response. Too severe an injury 
might kill far too many cells (including the microglia) or overwhelm the system to the 
point where the outcome measures are washed out. In essence, the goal was to produce an 
injury severe enough to substantially affect the most vulnerable cell population (neurons), 
while sparing the cell populations involved in the inflammatory response (astrocytes and 
more importantly, microglia). As detailed in this chapter, this proved more difficult to 
achieve than expected. It ultimately required an overhaul of the culture method as well as 
a complete shift in the mechanism of injury delivery. However, such changes were 







4.2 Improvement of custom-manufactured 3-D culture and injury chambers 
4.2.1 Previously-developed injury devices 
The initial method employed to impart mechanical deformation to the 3-D 
multitypic neural cell cultures was a custom-made 3-D cell shearing device (CSD) [61]. 
This system utilized custom-made, silicone-walled dual culture chambers adhered to 
glass coverslips set in a polycarbonate frame for interface with the cell shearing 
mechanism. For injuries, the chamber was held fixed while a polycarbonate top plate 
with silicone pads made contact with the 3-D cultures and delivered a prescribed shear 
deformation via an attached PID-controlled actuator. While this well-designed system 
delivered consistent shear injuries, it was not without limitations. Most of these stemmed 
from the method of manufacture. The machined polycarbonate components were milled 
in such a way that only matching pairs of top and bottom plates would sufficiently align 
for use in the device. This led to generating 3-D cultures in standard multiwell plates and 
transferring them to the custom chambers for injury followed by transfer back to the 
multiwell plates. While this did not present an experimental problem in the properly 
controlled experiments in which this system was employed, it was far from streamlined.  
Ideally, the 3-D cultures would be grown and injured in the same chamber, 
eliminating the need for transfer of the delicate cell-seeded matrices. While this could be 
achieved using the existing chambers, the need to match the top plate to its bottom mate 
would require attachment of the appropriate top plates to the actuator for each injury. 
Additionally, preparing the chambers for culture use proved difficult as the mixed 
composition of the chambers (silicone, glass, and plastic) led to incompatibility with one 




separate culture chambers consisting solely of silicone and glass that could be inserted 
into the plastic assembly at the time of injury. This would eliminate the need to 
physically transfer the cultures as well as require only a single plastic assembly to carry 
out all injuries. Producing such a modular design using available milling machines was 
not feasible due to the grooves necessary to allow insertion of the culture chamber into to 
injury frame. In the interest of enhancing the reproducibility of in vitro injury 
experiments, and due to the availability of the resource, the redesigned injury system was 
generated using 3-D printing technology. 
In addition to the CSD, in vitro injury was also imparted using a 3-D cell 
compression device (CCD) [62]. This system delivered mechanical load to 3-D cultures 
by means of a 10 mm diameter piston driven by a linear actuator controlled by the same 
PID controller as the CSD. The strains and strain rates possible with the CCD were 
comparable to those achievable using the CSD. While the CCD did not have the same 
limitations as the CSD, it was also modified to be compatible with the improved chamber 
slides using 3-D printed parts. Additionally, rapid prototyping allowed for simplified 
generation of pistons with different diameters. 
4.2.2 Manufacture of in vitro chamber slides, CSD chambers, and CCD components 
 4.2.2.1 Culture chamber slides 
The silicone walls of 3-well chamber slides were made of Sylgard 184® (Dow 
Corning, Midland, MI) polydimethylsiloxane (PDMS) cast in reusable 3-D printed molds 
made of Objet FullCure® 950 Tango Gray material (printed by RedEye, Eden Prairie, 
MN). All CAD files for the culture as well as the injury components were created using 




slide, the silicone walls were adhered to 75mm x 25mm plain glass slides using Dow 
Corning® 734 flowable sealant (Figure 4.1). Although the use of glass coverslips with the 
previous model allowed for the use of high-power microscope objectives with short 
working distances, glass slides provided the durability required for insertion into and 
removal from the in vitro injury chamber. 
4.2.2.2 CSD chambers 
 The modular shear injury chambers were generated using the same dimensions as 
the previous chambers so that no modifications to the injury device would be necessary. 
All parts of the shear injury chamber were printed using an Objet Eden 250 printer 
(Stratasys, Eden Prairie, MN) using Fullcure® 720 material. The complete chamber 
consists of three components: a frame into which the chamber slide can be inserted; an 
insert placed into the frame to secure the chamber slide; and a lid with “C”-shaped feet 
to which PDMS inserts are adhered such that when placed on top of the frame, gentle 
contact with the 3-D cultures is made (Figure 4.2). Numerous iterations of this design 
were manufactured to produce properly mating parts before carrying out injury 
experiments. This was required as working within the tolerances of the 3-D printer 
necessitated compensation for slight disparity in the dimensions of the printed piece 
versus the CAD file.  
4.2.2.3 CCD components 
 New pistons were created using the same dimensions as the previous milled 
polycarbonate components. The pistons were printed using Objet Fullcure® 720 material 






































Figure 4.2. Shear injury chamber assembly. (A) The chamber slide is inserted into the 
injury frame. (B,C) The insert is placed into the frame to secure the chamber slide. (D) 
















Figure 4.3. 3-D printed compression injury device components. (A) The piston assembly 
with 10 mm piston inserted. (B) Right profile of the piston assembly. (C) The 




pads were adhered to the piston surface where it made contact with the 3-D cultures 
during injury. An additional modification to the CCD was to print a frame to hold the 
culture chamber slides during injury (Figure 4.3C). The upper dimensions of this frame 
were identical to the CSD injury frame. It was substantially taller to facilitate inserting 
and removing the chamber slides and also to position them within the range of the piston 
stroke. Detailed methods for the manufacture and preparation of the chamber slide, shear 
injury chamber, and compression injury components can be found in Appendix A. 
4.3 Experimental methods 
4.3.1 Chamber slide preparation 
 The glass and silicone chamber slides were designed to be completely reusable. 
Prior to 3-D plating, the slides were cleaned using detergent as well as both aqueous and 
organic solvents. Slides were rinsed with tap water, wiped with a cotton swab, and 
soaked in tap water containing dissolved powdered Alconox (Alconox, Inc., White 
Plains, NY) for at least 30 minutes on a rotary shaker. The sides were then rinsed with 
fresh tap water and then exposed to sequential 10 minute soaks in: deionized (DI) water, 
70% ethanol, acetone, 70% ethanol, and DI water. All of these steps were carried out on a 
rotary shaker. Sterilization was achieved by sealing the slides in steam sterilization 
pouches and autoclaving them at 127 ºC with a Tuttnauer 3850M benchtop autoclave 
(Tuttnauer, Hauppauge, NY). The slides were then transferred to 15 cm polystyrene 
culture dishes (4 slides per dish) and coated with 500 μL of 100 μg/mL PDL in DI water 
for 24-48 hours. On the day of plating, the PDL was removed and the wells were rinsed 
twice with 500 μL of sterile, DI water. The liquid from the culture chambers was 




completely in the laminar flow hood while tissue dissection and dissociation procedures 
were carried out. 
4.3.2 Cell culture 
3-D multitypic neural cell cultures were generated as discussed in Chapter 2 and 
as described in detail in Appendix A. Briefly, E18 rat cortical neurons were combined 
with cortical glial cells acquired from P0 rats at a 2:1 ratio of neurons to total glia. The 
cells were mixed with high-concentration, growth factor-reduced Matrigel™ (final plating 
protein concentration of 7.5 mg/mL) to a cell concentration of 4,000 cells/mm3. The 3-D 
cultures were plated at a volume of 100 μL or 200 μL into the custom-made chamber 
slides described in Section 4.2.2. The cells were maintained in an incubator at 37 ºC and 
95% relative humidity. The cultures were fed with medium containing G-5 supplement 
90 minutes after the initial plating (500 μL) and 24 hours post-plating (replacing half of 
the medium). All subsequent half-medium exchanges were with medium without G-5. 
All medium used for 3-D culture feedings was pre-warmed and pre-conditioned with CO2 
by placing an aliquot in a flask fitted with a filter cap into the incubator. 
4.3.3 Mechanical injury 
4.3.3.1 Shear injury 
 Preparation of the shear injury chamber for mechanical loading of the 3-D 
cultures consisted of rinsing the previously mentioned parts with DI water, spraying them 
with 70% ethanol, patting them dry, placing them into 15 cm polystyrene dishes and 
exposing them to UV light in a laminar flow hood for at least 1 hour. For injury, medium 
was removed from the cultures; the chamber slide was transferred to the plastic frame, 




inserts. Between injuries, the PDMS pads of the lid were wiped with 70% ethanol and 
then dipped in sterile medium. The entire assembly was transferred to the CSD where the 
frame secured in place and the top was attached to the linear actuator by means of a 
plastic chuck. Once assembled, the shear deformation was imparted to the cultures (2 per 
3-well chamber slide) by a PID-controlled linear actuator (Figure 4.4). A trapezoidal 
input was generated by custom code written in LabVIEW® (National Instruments, Austin, 
TX). The mechanical loading delivered 0.50 strain with strain rates of 10 sec-1 or 30 sec-1. 
Sham controls were placed into the injury chamber and CSD but not subjected to 
mechanical loading. After exposure to injury or sham conditions, cultures were given 
fresh medium and returned to the incubator. Naïve conditions simply consisted of a 
medium change and were included to ensure that the sham condition did not impart injury 
to the cultures. Confirmation that the lid of the injury chamber was moving with the 
impulse of the actuator while the chamber slide remained fixed was obtained using 
registration marks and a microscope during device activation. 
4.3.3.2 Compression injury 
 Chamber slides were transferred directly to the CCD for injury as the frame and 
piston remained affixed to the device. Prior to injury experiments, the frame and piston 
were wiped down with 70% ethanol and allowed to dry. Medium was removed from the 
cultures and the chamber slide was transferred to the device in a 10 cm polystyrene dish. 
Once inserted in to the CCD, the stage was moved to position each culture beneath the 
piston (8 mm or 10 mm diameter) for injury. The same controller and LabVIEW® 
software from the CSD were used to deliver the mechanical load. The piston was driven 












Figure 4.4. Shear injury illustration. (A) The shear injury lid is positioned above 3-D 
cultures. (B) The lid is lowered to gently compress the cultures to a uniform thickness. 
(C) A linear actuator rapidly displaces the lid relative to the fixed-position cultures, 




velocities ranging over an order of magnitude between 30 mm/s and 500 mm/s. For low 
velocity compression injuries (30 mm/s), the piston was lowered to make contact with the 
culture surface prior to device activation. For compression at all other velocities, the 
piston was above the culture prior to activation. For sham injuries, the piston was 
manually advanced to gently make contact with the culture surface and slowly retracted. 
Between each injury, the PDMS surface of the piston was swabbed with 70% ethanol and 
dried. After exposure to injury or sham conditions, the cultures were given fresh medium 
and returned to the incubator. Naïve conditions were the same as for the shear injury 
experiments. 
4.3.4 Outcome measures 
4.3.4.1 Cell viability 
 Cell viability was determined by using calcein AM and ethidium homodimer to 
identify live and dead cells, respectively, or by using Hoechst 33342 and propidium 
iodide to identify all cells and dead cells, respectively. 3-D cultures were rinsed with 
DPBS, exposed to the fluorescent markers (in DPBS) for 30 minutes, and imaged using a 
Nikon Eclipse 80i upright microscope equipped with a MicroFIRE camera. Images from 
three fields from each culture were captured at 10X magnification using both appropriate 
fluorescent filters. Each channel was individually thresholded in Adobe Photoshop CS4 
and cells or nuclei were counted using defined parameters in ImageJ software. For some 
experiments, 3-D cultures were exposed to propidium iodide prior to mechanical injury to 
identify dead cells or cells with compromised plasma membranes. Imaging was carried 





4.3.4.2 LDH Assay 
 Culture medium was collected at time points ranging from 1 hour to 24 hours 
post-injury. Levels of LDH were determined colorimetrically using an In Vitro 
Toxicology Assay Kit and a Power Wave X 340 spectrophotometer (Bio-Tek 
Instruments, Inc., Winooski, VT) operated using KC Junior Software (Bio-Tek). The data 
were compared to that from cultures treated with 0.1% Triton X-100 for 30 minutes to 1 
hour prior to medium collection to establish maximum LDH release. 
4.3.4.3 Immunocytochemistry 
 Complete cultures processed for immunocytochemistry were fixed with 2% 
paraformaldehyde in PBS, permeabilized with 0.1% Triton X-100, incubated with 
primary antibody overnight at 4 ºC and with secondary antibody for 1-2 hours at room 
temperature. All solutions for immunolabeling (including rinse buffer) contained 0.05% 
saponin. Cultures were probed using primary antibodies against MAP2, GFAP, and Iba1. 
Hoechst 33342 was used as a nuclear counterstain. 
4.3.4.4 Statistical analysis 
 Data were statistically compared using one-way ANOVA followed by a post-hoc 
Tukey-Kramer test for multiple comparisons if ANOVA yielded a result of p<0.05.  
4.4 Shear injury of 3-D multitypic neural cell cultures 
 In order to demonstrate the ability to inflict cellular damage using the improved 
culture and injury system, pilot experiments were performed in which cell viability was 
assessed after shear injury. Cultures maintained for 25 DIV were subjected to shear injury 
(n=8), sham injury (n=4), or no injury (n=2). Live-dead assessment using calcein AM and 




in both the sham (p<0.01) and injury (p<0.05) conditions compared to the naïve condition 
(Figure 4.5A). The viability of the sham and injured cultures did not differ significantly. 
The accuracy of these data was questioned due to the difficulty in determining cell 
boundaries when processing the calcein AM data. As discussed in Section 3.2.6, the 
projection of 3-D fluorescent signal onto a 2-D image coupled with the cytosol-filling 
labeling of the calcein AM led to the decision to perform viability assessment exclusively 
using nuclear markers. This would allow for more discrete labeling of the cultured cells. 
Cultures maintained for 19 DIV were subjected to shear injury (n=8), sham injury (n=4), 
or no injury (n=4) as before. Cell viability determined using Hoechst 33342 and 
propidium iodide 48 hours after injury revealed no significant reduction in viability in 
response to injury (Figure 4.5B). These experiments were repeated at various time points 
and with minor modifications to the injury chamber, but did not consistently demonstrate 
that any significant cell death was occurring in response to shear injury. 
4.5 Compression injury of 3-D multitypic neural cell cultures 
 Pilot experiments using compression injury were carried out to determine if 
changing the means of mechanical loading would prove more successful at delivering 
mechanical injury. In addition to the change in the method of mechanical injury, the 
method of cell viability assessment was changed to LDH release to increase accuracy and 
sensitivity. The initial compression injury experiments using previously employed 
velocity parameters (30 mm/s) did not show any increase in LDH release in response to 
injury. Thus, higher velocity conditions were added. Cultures maintained for 7 DIV were 
subjected to compression injury with an 8 mm diameter piston to a depth of 0.50 mm at 













Figure 4.5. Determination of cell viability in response to shear injury using fluorescent 
markers. (A) 24 hours after cultures (25 DIV) were subjected to shear injury (0.50 strain, 
30s-1) (n=8), to sham injury (n=4), or to no injury (n=2), a Live-Dead assay was 
performed using Calcein AM and ethidium homodimer to label viable and dead cells, 
respectively. Cell viability is significantly reduced in both the injury (p<0.05) and sham 
(p<0.01) conditions compared to the naïve control. The sham and injury conditions are 
not significantly different from each other. (B) 48 hours after cultures (19 DIV) were 
exposed to shear injury (0.50 strain, 30s-1) (n=8), to sham injury (n=4), or to no injury 
(n=4), viability was assessed using Hoechst 33342 and propidium iodide to label the 
nuclei of all cells and dead cells, respectively. This method shows no significant 
difference between any of the conditions. Data were statistically compared using one-
way ANOVA followed by a post-hoc Tukey-Kramer test for multiple comparisons, if 





 (n=2) conditions. LDH release 24 hours after injury progressively increased with 
increasing velocity (Figure 4.6). However, due to the small sample size, the only 
significant difference was between the maximum velocity (500 mm/s) and the naïve 
control (p<0.05). 
Based on the promising trend of the pilot data, further compression injury 
experiments were conducted with a key change to the culture method. Cultures had 
typically been plated at a volume of 200 μL such that filling the 200 mm2 well would 
result in a gel with a thickness of 1 mm. However, filling the bottom of the well to the 
walls caused a meniscus to form and prevented either injury method from being effective. 
Rather, the cultures were plated such that the gel would cover as much area as possible 
without making contact with the wall. The resulting cultures were thicker in the center 
than at the edges. Phase contrast microscopy clearly indicated that at the surface of the 
chamber slide, the center of the gel was nearly devoid of viable cells. As this would 
certainly be affecting the viability data, cultures were subsequently plated at a volume of 
100 μL. These looked substantially healthier at their thickest point, which was closer to 
the desired thickness of 1 mm. 
To assess the time course of LDH release after mechanical insult, 100 μL cultures 
maintained for 13 DIV were subjected to compression injury with a 10 mm diameter 
piston (500 mm/s velocity, 0.50 mm depth) or to sham injury. Medium was collected 
from injured cultures at 2, 4, and 8 hours (n=3 each) and from sham cultures at 8 hours 
(n=3). The LDH activity in the medium of the injured cultures increased with time and at 
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Figure 4.6. Determination of cell viability in response to compression injury by LDH 
release. Cultures (7 DIV) were subjected to compression injury (8 mm piston diameter, 
0.50 mm depth) at velocities of 30 mm/s (n=2), 100 mm/s (n=2), and 500 mm/s (n=4), as 
well as to sham (n=2) and naïve (n=2) conditions. LDH release in the medium increases 
with increasing piston velocity. The 500 mm/s injury is significantly different than the 
sham condition (p<0.05). Data were statistically compared using one-way ANOVA 





The maximum actuator velocity for which the output closely matched the input 
was 500 mm/s. Thus, to achieve an increase in injury severity, another parameter would 
have to be modified. The simplest options were piston diameter and compression depth. 
Since the piston diameter had already been increased to 10 mm, the effect of compression 
depth was assessed. Cultures maintained for 12 DIV were subjected to a compression 
injury with a 10 mm diameter piston to a depth of 0.50 mm or 1.00 mm into the culture 
(n=3 each) or to a sham injury (n=3). The LDH activity in the injured culture medium 20 
hours after injury is significantly higher than the sham at both injury depths (p<0.001) 
(Figure 4.8A). Further, LDH release from the 1.00 mm injury is significantly higher than 
that from the 0.50 mm injury, registering greater than 100% LDH activity. The 
compromised astroglial morphology and near absence of MAP2-positive neurons in the 
images collected from immunocytochemical analysis of the cultures corroborates the 
severity of the 1.00 mm injury (Figure 4.8F,G). However, the morphology of the cells 
subjected to the 0.50 mm injury (Figure 4.8D,E) does not appear substantially different 
from the sham (Figure 4.8B,C) 
4.6 Conclusions 
 This chapter has described the evolution of the in vitro injury model for the 3-D 
multitypic neural cell cultures. Using the materials and parameters of the previously 
described model for neuron-astrocyte co-culture injury failed to produce injured cells in 
the microglia-containing cultures. Neither cell viability nor levels of LDH were affected 
when shear injuries up to 0.50 strain and strain rates up to 30 s-1 were delivered. Given 
the severity of injury that such mechanical loading was expected to impart, this result was 
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Figure 4.7. Time course of LDH release in response to compression injury. Cultures (13 
DIV) were subjected to compression injury (10 mm piston diameter, 500 mm/s velocity, 
0.50 mm depth) or to sham injury. The level of LDH in the medium was determined at 2, 
4, and 8 hours (n=3 each) and from the sham cultures at 8 hours (n=3). LDH activity in 
the medium increases with time after compression injury and was significantly different 
from sham at both 4 and 8 hours (p<0.001). Data were statistically compared using one-
way ANOVA followed by a post-hoc Tukey-Kramer test for multiple comparisons. Bars 





Figure 4.8. The depth of piston compression into the culture decreases cell viability and 
affects cell morphology. Cultures (12 DIV) were subjected to compression injury (10 mm 
piston diameter, 500 mm/s velocity) to a depth of 0.50 mm or 1.00 mm or to a sham 
injury (n=3 each). (A) LDH activity in the medium is significantly higher than sham for 
both injury conditions (p<0.001). Cultures were incubated with antibodies against GFAP 
(B,D,F, green) or MAP-2 (C,E,G) to label astrocytes and neurons, respectively, as well as 
with Hoechst nuclear counterstain (B,D F, blue). The cells do not exhibit morphological 
differences in the 0.50 mm injury (D,E) compared with the sham injury (B,C). GFAP 
fibers in both conditions are intact (arrows). There is a substantial degradation in the 
astrocyte fibers (arrowheads) and a near absence of neurons in the 1.00 mm injury (F,G) 




was ameliorating the injury response via induction of macrophage-like activity, and after 
24 hours the response was not detectable using the chosen outcome measures. However, 
experiments in which the cultures were pre-loaded with propidium iodide, injured, and 
immediately imaged also failed to show any cell death. Another explanation is that 
despite the advantages of the updated culture and injury chamber design, it is possible 
that the prescribed mechanical load was not being accurately delivered to the cultures. 
However, injuries carried out using the previously manufactured chambers also failed to 
demonstrate cell death when compared to sham controls. Further, were the new chambers 
posing a problem to the injury model, the implementation of compression injury should 
not have been affected as the chamber has no effect on the load delivery. Indeed, 
compression injury experiments using previously employed parameters also failed to 
injure the cells. Ultimately, it was found that a piston velocity of over an order of 
magnitude higher than previously used was required to reliably damage the cells as 
measured by LDH activity and confirmed with immunocytochemistry. 
 The optimized injury system described in this chapter is comparable to other 
methods of delivering mechanical trauma in vitro. Using the previous 3-D neuron-
astrocyte co-cultures, both shear and compression injury increased cell permeability to 
calcein in a strain-rate-dependent manner while only high strain-rate shear injury 
significantly decreased cell viability [62]. Cell injury and death have been demonstrated 
in 2-D neuronal cultures grown on flexible substrates. Stretch injury of 2-D primary rat 
neurons has been shown to induce cell permeability to calcein [169]. Biaxial stretch 
injury of SH-SY5Y cells was demonstrated to induce both cell injury and death in a 




exhibited increased LDH activity in response to injury delivered by impact with a custom 
punch [171] and by stretch [172]. The latter response was shown to be enhanced by 
hypoxia. Although hypoxic conditions were not tested in the system presented there, they 
could easily be included in future studies. In hippocampal slice cultures, membrane 
permeability demonstrated by propidium iodide uptake has been demonstrated in 
response to injuries delivered by weight drop [173], by stretch [43], and by electrically-
controlled cantilever [174, 175]. The compression injury model described in this chapter 
demonstrated injury-induced membrane permeability indicated by propidium iodide 
uptake as well as cell death based on the time-dependent elevation of LDH activity in the 
medium. The final design allows for delivery of a graded injury through modification of 
piston diameter, piston velocity, and penetration depth. The data presented here have 
shown that changing one or more of these parameters can result in injury levels ranging 
from nearly zero cell death to nearly complete destruction of the culture. Such a wide 
dynamic range allows for flexibility in designing experiments to model different 
severities of TBI in vitro. 
 Despite the unexpected changes to the injury parameters, the resulting protocol 
has a notable advantage in that it is closer to the in vivo CCI model. Although piston 
velocities used in CCI are a further order of magnitude higher than 500 mm/s, the 
mechanics of intact tissue (including the presence of the dura mater) are far different than 
those of a relatively soft hydrogel seeded with neural cells. Thus, this in vitro model of 
mechanical injury may not only serve as a standalone platform for the study of 
neuroinflammation, it may be directly comparable, if not translatable, to an in vivo 




of the inflammatory potential of these cultures in Chapter 3, the application of 
mechanical loading to the 3-D multitypic neural cell cultures should be sufficient to 
induce inflammation in vitro. This assertion assumes that the appropriate signaling 
pathways can be triggered in a culture model that, although it includes microglia, still 
lacks some of the key players in inflammation. Even in the absence of the complete 
picture of neuroinflammation, this model will provide insight into some facets of the 





MECHANICAL INJURY-INDUCED NEUROINFLAMMATION IN THE 3-D 
MULTITYPIC NEURAL CELL CULTURE SYSTEM 
5.1 Introduction 
  The ultimate goal of this research was to develop an in vitro model of 
neuroinflammation that is triggered by mechanical injury. The benefits of such a model 
include: consistency of the 3-D cultures, repeatability of injury delivery, and potential for 
high-throughput experiments. Despite the stripped-down nature of the in vitro system, the 
3-D geometry and novel cellular composition of the cultures was believed to result in a 
model that captured microglia-driven inflammatory responses. Previous chapters have 
detailed the creation of the novel 3-D multitypic neural cell culture system, validation of 
the induction of inflammation in this system by chemical stimulation, and the evolution 
of a mechanical injury method for 3-D cultures. The next step was to attempt to produce 
an inflammatory response to mechanical loading in vitro that was on par with the 
response induced by the LPS positive control.  
The initial choice of outcome measures used to assess the state of inflammation of 
the cultures was guided by the success of those that were employed for the LPS 
experiments detailed in Chapter 3. Some of the mechanical injury experiments presented 
in this chapter were performed in tandem with these LPS experiments. Specifically, IL-1β 
was chosen as the cytokine of interest due to its role in the injury response as well as the 
increased levels of the molecule at both the protein and mRNA level in response to LPS 
stimulation. Also, given the involvement of purinergic signaling in the activation of 




injured cells would provide the appropriate stimulation for IL-1β release. The release of 
other molecules such as superoxide and NO were also examined in order to obtain a more 
complete picture of the inflammatory response of the cultures. 
As with the development of the mechanical injury model to sufficiently impart 
injury to the cultures, eliciting an inflammatory response proved to be more difficult than 
expected. Inconsistencies in culture geometry and related issues with mechanical injury 
led to minor modifications to the culture chamber slide and to the compression injury 
device, respectively. However, even with these modifications, the experiments were met 
with uneven success as the data presented in this chapter will illustrate. Despite this, the 
groundwork laid by these experiments provides a solid foundation for an in vitro model 
of mechanically-induced neuroinflammation. 
5.2 Final modifications to the culture and injury systems 
 During the course of the experiments presented in this chapter, modifications 
were made to the medium used for maintaining the 3-D cultures. Standard B-27 
supplement contains antioxidants, including superoxide dismutase, which could certainly 
interfere with inflammation processes. While the presence of antioxidants in the medium 
did not interfere with the detection of IL-1β and NO upon LPS stimulation, this response 
may have simply overwhelmed any damping effects of the antioxidants. In order to 
improve the detection of the potentially subtler inflammatory response to mechanical 
injury, antioxidant-free B-27 was used in all media formulations for the microarrays as 
well as for the experiments utilizing dyes sensitive to NO and ROS. 




 In another attempt to prevent the potential masking of mechanically-induced 
inflammation, the use of phenol red-free base medium was implemented for the same 
experiments. It has been suggested that medium preparations containing phenol red may 
possess estrogen-like activity [176-178] and estrogen is known to interfere with 
inflammatory processes in microglia [179, 180] and astrocytes [181]. A further advantage 
of eliminating phenol red was the removal of potential interference with colorimetric or 
dye-based assays. It should be noted that stock Matrigel™ preparations still contained 
phenol red from the gel as well as from the HBSS diluent. However, after repeated 
feedings with phenol red-free medium, this was reduced to a negligible level. 
 As mentioned briefly in Chapter 4, when plating the 3-D cultures in the custom 
made chamber slides, the options for the culture geometry were for the gel to be thickest 
at the edges (meniscus effect) or at the center. In addition to the contributions of gel 
surface tension and the varying contact angles for wetting the PDL-coated glass and 
silicone surfaces, the protein content and thermal sensitivity of the Matrigel™ contributed 
to meniscus formation if the gel was permitted to touch the sides of the culture chamber. 
Rather, the alternative situation in which the gel remained as a roughly square-based 
dome was preferred such that the cultures would be able to make contact with the shear 
or compression injury devices. However, inconsistencies between cultures remained due 
to human variability in dispensing the gel and in the spreading of the gel on the glass 
surface. It was noted that despite exposure to organic solvents before reusing the chamber 
slides, the contact angle between the gel and the glass surface would decrease with 
repeated use. Thus, cultures spread more easily when plated into older chamber slides. 




Beyond these concerns, the variability of thickness within a single culture would 
certainly cause a diffusion-dependent gradient of nutrient availability. This was the cause 
of the aforementioned issue with the cell death observed at the bottom of the 200 μL 
cultures which resulted in a shift to using a volume of 100 μL. 
 To address these issues, it was determined that the ideal culture geometry would 
be a square of uniform 1 mm thickness. However, due to the issues with meniscus 
formation, this proved quite difficult to achieve. Allowing for the meniscus to form and 
then backfilling the cavity with more cell-seeded Matrigel™ was considered, but never 
attempted as the geometry would likely remain inconsistent. Neither pre-heating nor pre-
cooling of the chambers prior to gel prevented the meniscus from forming. As would be 
expected, this did affect the spreading of the gel as the warmer the substrate, the more 
rapidly polymerization occurred. Decreasing the surface tension of the PDL solution with 
isopropyl alcohol during coating was attempted to limit the height the PDL would climb 
the silicone wall. While this was successful for the coating phase, the stickiness of the gel 
due to protein content still resulted in a meniscus. Coating the walls of the wells with 
paraffin wax as previously described for invasion assays utilizing well inserts [182] was 
also unsuccessful and additionally left wax debris in the cultures. Finally, it was 
determined that the gel climbing the walls would be limited if the wall height was 
decreased. Thus, a new culture chamber was created consisting of 3 wells, each with a 
surface area of 150 mm2 and a depth of 1 mm within the full size wells (Figure 5.1). 
Thus, the volume of each smaller culture well was 150 mm3 so that 150 μL of cell-seeded 
Matrigel™ would completely fill it to the top of the 1 mm rim resulting in a flat 3-D 
















Figure 5.1. Redesigned chamber slide to facilitate the plating of 3-D cultures of uniform 
1 mm thickness. (A) Molds for casting the silicone culture wells were printed in Objet 
FullCure® 950 Tango Gray material. (B) The completed culture chamber consists of 
three silicone-walled wells in a single piece adhered to a glass slide. The lip around the 




viability was observed throughout the thickness of the culture. Additionally, the flat 
cultures had the advantage that a lower volume of culture medium could be used since 
the uniform culture thickness was not as easily exposed by the fluid meniscus. While 
cultures were maintained with 400 μL of medium, for injury experiments, the volume 
was reduced to 200 μL post-injury to concentrate any released factors for endpoint 
assays. 
5.2.3 Change in piston diameter for compression injury device 
 One issue that arose with the new culture chamber was that the diameter of the 
compression injury piston had to be reduced. Since the sides of the culture were now 
constrained, compressing a square culture approximately 12.5 mm on a side with a 10 
mm diameter piston caused the gel to displace upward which resulted in a devastating 
injury. In some cases, the culture would stick to the piston and pull away from the glass 
surface during retraction. Aside from this technical issue, it made sense to decrease the 
piston diameter from the standpoint of modeling neuroinflammation. The goal for the 
injury model was to cause enough cellular damage to result in the activation of pro-
inflammatory pathways without causing culture-wide necrosis. Using this new flat 3-D 
culture and a smaller piston diameter would create a radial injury gradient. Ideally, three 
areas of the culture would be present post-injury: an injury umbra under the piston where 
cells experienced severe mechanical damage, an injury penumbra surrounding the umbra 
where cells experienced varying levels of compression and strain, and an uninjured 
region beyond the penumbra where cells experienced little to no deformation. It was in 
the penumbral region where the microglial response to injury was expected to be the 




impart compression rather than creating a cavity. This piston size would severely injure 
approximately 10% of the culture and hopefully generate an observable penumbra where 
an inflammatory response to injury could be detected. Additionally, three pistons were 
combined into a single 3-D printed part (Figure 5.2) so that all three cultures present on 
each chamber slide could be injured simultaneously, increasing throughput dramatically.  
5.3 Experimental methods 
5.3.1 Cell culture 
3-D multitypic neural cell cultures were generated as discussed in Chapter 2 and 
as described in detail in Appendix A. Briefly, E18 rat cortical neurons were combined 
with cortical glial cells acquired from P0 rats at a 2:1 ratio of neurons to total glia. The 
cells were mixed with high-concentration, growth factor-reduced Matrigel™ (final plating 
protein concentration of 7.5 mg/mL) to a cell concentration of 4,000 cells/mm3. The 3-D 
cultures were plated into custom-made chamber slides as 100 μL dome-shaped cultures 
or as 150 μL flat cultures, as indicated. The cells were maintained in an incubator at 37 
ºC and 95% relative humidity. The cultures were fed with medium containing G-5 
supplement 90 minutes after the initial plating (500 μL for dome-shaped cultures or 400 
μL for flat cultures) and 24 hours post-plating (replacing half of the medium). All 
subsequent half-medium exchanges were with medium without G-5. All medium used for 
3-D culture feedings was pre-warmed and pre-conditioned with CO2 by placing an 
aliquot in a flask fitted with a filter cap into the incubator. 
5.3.2 Compression injury 
Between 7 and 14 DIV, medium was removed from the cultures and the chamber 


















Figure 5.2. New 3-D printed compression injury pistons (A) The assembly with three 4 




experiments, the frame and piston were wiped down with 70% ethanol and allowed to 
dry. Cultures were injured either individually using the 10 mm diameter piston or three at 
a time using the multiple 4 mm diameter pistons. The piston was positioned above the 
center of the cultures and driven to a depth of between 0.50 mm and 1.00 mm from the 
surface of the culture at a velocity of 500 mm/s. For sham injuries, the piston was 
manually advanced to gently make contact with the culture surface and slowly retracted. 
Between each injury, the PDMS surface of the piston was swabbed with 70% ethanol and 
dried. After exposure to injury or sham conditions, the cultures were given fresh medium 
and returned to the incubator. Naïve conditions were either transferred to the device 
briefly and given fresh medium or simply received a medium change. 
5.3.3 Addition of adult mouse microglia 
 Adult microglia were harvested from C57/BL6 (heterozygous for GFP on 
CXCR1/Fractalkine promoter) mice according to a published protocol [183]. Briefly, 
whole brains were removed from adult mice and minced in cold PBS. The tissue was 
enzymatically dissociated using a cocktail of dispase II, papain, and DNase for 20 
minutes at 37 ºC. The tissue was then rinsed and mechanically dissociated using a series 
of Pasteur pipets flame-narrowed to decreasing diameters. The resulting suspension was 
filtered through a 40 μm cell strainer and centrifuged twice for at 250 rcf for 5 minutes 
with a rinse in between. The pellet was resuspended in HBSS containing 37% Percoll. A 
density gradient was generated by layering this suspension atop a 70% Percoll solution 
and subsequently layering a 30% Percoll solution atop the suspension. After 




the interface between the 70% and 37% Percoll layers. The cells were collected, 
centrifuged at 800 rcf for 5 minutes, and resuspended with 3-D culture medium. 
 The adult microglia were introduced to 3-D cultures (150 μL, flat) maintained for 
7 DIV either by direct dropwise addition (15,000 cells/culture) to the medium or by 
mixing the cells with Matrigel™ and pipeting this gel (5,000 cells/culture) into a pocket 
created in the corner of the 3-D cultures at the time of their plating. The cultures were 
maintained for an additional 7 DIV before being subjected to LPS stimulation (0.1, 1, or 
10 μg/mL final concentration) or to compression injury (4 mm piston diameter, 500 mm/s 
velocity, 1.00 mm depth). The latter was delivered to the center of the culture if the adult 
microglia had been added dropwise or adjacent to corner where the cells dispersed in 
Matrigel™ were plated. The response of the GFP positive microglia was followed by 
fluorescence microscopy over the course of 3 days, and fluorescent images were acquired 
using a Nikon Eclipse 80i upright microscope (Nikon Instruments, Melville, NY ) 
equipped with a MicroFIRE camera (Optronics®, Goleta, CA). 
5.3.4 Outcome measures 
5.3.4.1 IL-1β ELISA 
 At specified time points after injury, medium was collected from each of the 
cultures into Eppendorf tubes and centrifuged at 1,000 rcf to remove any contaminating 
cells. The supernatants were transferred to fresh Eppendorf tubes and assayed 
immediately or frozen at -80 ºC. The samples were thawed and analyzed with a rat IL-1β 






5.3.4.2 Western blot 
At specified time points after injury, cultures were rinsed with cold PBS 
containing “cOmplete” PIC, collected with BD™ Cell Recovery Solution containing PIC, 
and pooled into Eppendorf tubes. Sample pooling of three cultures was necessary to 
ensure sufficient protein for loading the SDS-PAGE gel. The tubes were kept on ice for 
one hour with frequent inversion to facilitate the disintegration of the Matrigel™. The 
samples were centrifuged at 1,000 rcf at 4 ºC for 5 minutes and the pellets were 
resuspended with a protein extraction solution containing NP-40, deoxycholate, and PIC. 
The tubes were kept on ice and vortexed periodically during 1 hour of protein extraction. 
The samples were centrifuged at 1,000 rcf at 4 ºC for 5 minutes and the supernatants were 
transferred to fresh Eppendorf tubes. Protein content was determined by BCA protein 
assay (Pierce™/Life Technologies, Carlsbad, CA) and the samples were diluted to equal 
protein concentrations with SDS-PAGE sample loading buffer. The reduced and 
denatured samples were separated in 8-16% Tris-Glycine gradient SDS-PAGE gels 
(Invitrogen™/Life Technologies, Carlsbad, CA) and wet-transferred to PVDF membrane 
(EMD Millipore, Billerica, MA) for antibody detection. The membrane was blocked with 
Odyssey® Blocking Buffer (LiCor, Lincoln, NE), exposed to anti-rat IL-1β antibody 
(R&D Systems) overnight at 4 ºC. The membrane was incubated with secondary antibody 
conjugated to IR Dye 800 (Rockland Immunochemicals Inc., Pottstown, PA) and scanned 
using an Odyssey® infrared scanner (LiCor). 
5.3.4.3 Immunocytochemistry 
Cultures (150 μL, flat) maintained for 21 DIV were subjected to compression 




naïve condition, or to LPS stimulation (10 μg/mL final concentration) (n=3 each). After 
24 hours, cultures were fixed with 2% paraformaldehyde in PBS for 30 minutes and 
permeabilized with 0.1% Triton X-100 in blocking buffer containing 10% normal horse 
serum. The cultures were incubated with goat anti-rat IL-1β primary antibody (R&D 
Systems) overnight at 4 ºC and with FITC-conjugated donkey anti-goat secondary 
antibody (Jackson ImmunoResearch, West Grove, PA) for 1 hour at room temperature. 
Antibody solutions contained 1% serum. All solutions for immunolabeling (including 
rinse buffer) contained 0.05% saponin, a mild, reversible detergent. Fluorescent images 
were acquired using a Nikon Eclipse 80i upright microscope equipped with a MicroFIRE 
camera. 
5.3.4.4 mRNA microarray 
Cultures (150μL, flat) maintained for 14 DIV were exposed to injury (4 mm 
piston diameter, 500 mm/s velocity, 1.00 mm depth), sham, naïve, or LPS conditions. 
Four hours after injury, the cultures were rinsed twice with cold PBS. The Matrigel™ 
matrix was degraded by treating the cultures with BD™ Cell Recovery Solution for 2 
hours on ice with agitation on an orbital shaker. Two cultures were pooled to represent a 
single sample, which resulted in 3 samples for each treatment condition (n=3). The 
sample pooling was determined in preliminary experiments to be necessary to generate 
enough RNA for the microarrays. Total RNA was extracted with TRIzol Reagent (Life 
Technologies), quality controlled, and quantified by Agilent 2100 Bioanalyzer (Agilent 
Technologies, Santa Clara, CA). Microarrays were completed according to 
manufacturing guidelines (Affymetrix® Inc., Santa Clara, CA), with cRNA hybridized to 




hybridized at 45°C for 16 hours, washed, stained with streptavidin-phycoerythrin, and 
scanned according to manufacturing guidelines. Three chips were used for each 
experimental group. 
5.3.4.5 Direct NO detection using NO-sensitive dye 
 Cultures (150 μL, flat) maintained for 13 DIV were subjected to compression 
injury (4 mm piston diameter, 500 mm/s velocity, 1.00 mm depth), to sham injury, to a 
naïve condition, or to LPS stimulation (10 μg/mL final concentration). After 24 hours, the 
cultures (n=3 for each condition) were rinsed with DPBS and subsequently exposed to an 
NO-sensitive hydrocyanine infrared dye (in DPBS) for 1 hour. The cultures were rinsed 
with DPBS and imaged using an IVIS Lumina® near-infrared imaging system (Perkin 
Elmer, Waltham, MA). 
5.3.4.6 Griess assay for nitrite production 
Cultures (150 μL, flat) maintained for 13 DIV were subjected to compression 
injury (4 mm piston diameter, 500 mm/s velocity, 1.00 mm depth), to sham injury, to a 
naïve condition, or to LPS stimulation (10 μg/mL final concentration). After 24 hours, 
medium was collected from each of the cultures (n=6 for each condition) and the level of 
nitrite present was determined. Nitrite is a stable breakdown product of NO and was 
detected using a two-step colorimetric diazotization reaction known as a Griess assay 
(Promega, Madison, WI) according to the manufacturer’s instructions. 
5.3.4.7 Direct ROS detection with superoxide-sensitive dye 
 Cultures (100 μL) maintained for 8 DIV were rinsed with DPBS and subsequently 
exposed to hydro-indocyanine green (H-ICG) (250 μM in DPBS), an infrared dye 




subjected to compression injury (10 mm piston diameter, 500 mm/s velocity) to a depth 
of either 0.75 mm or 1.00 mm or to sham injury (n=3 for each condition). Additionally, 
there was a set of cell-free Matrigel™-only controls (n=3) that were treated as a naïve 
condition would have been. DPBS was added to the cultures and each chamber slide was 
covered with a custom-made lid consisting of FEP membrane over a 3-D printed frame of 
Fullcure® 720 plastic and imaged using an IVIS Lumina® system at time points up to 13 
hours post-injury. The custom-made lids prevented buffer evaporation which had been 
shown in a previous experiment to result in a constantly increasing fluorescent signal 
over the time course. 
5.3.4.8 Statistical Analysis 
Data from experiments comparing two treatment conditions were statistically 
compared using a one-tailed, unpaired t-test with Welch’s correction for unequal 
variances where appropriate. Data from experiments comparing more than two treatment 
conditions were statistically compared using one-way ANOVA followed by a post-hoc 
Tukey-Kramer test for multiple comparisons if ANOVA yielded a result of p<0.05. 
5.4 Effect of in vitro compression injury on IL-1β 
5.4.1 Extracellular IL-1β release 
 It was hypothesized that mechanical injury of the 3-D multitypic neural cultures 
would initiate an inflammatory response and that IL-1β would be a marker for this 
induced inflammation. Cultures (100 μL) maintained for 13 DIV were subjected to 
compression injury (10 mm piston diameter, 500 mm/s velocity, 0.50 mm depth) or to 
sham injury. Medium was collected at 4 hours (n=6 for each condition). Medium was 




The ELISA data show that IL-1β was essentially undetectable in either the sham or injury 
condition (Figure 5.3). All measured absorbance values for these conditions were lower 
than the lowest nonzero standard. Similar cultures, from which the medium was collected 
at 24 hours after injury, had detectable levels of IL-1β in the culture medium but showed 
no significant difference among the naïve, sham, and injury conditions (not shown). 
In order to develop a picture of the potential time dependence of IL-1β detection, 
the amount of IL-1β released in response to mechanical injury was measured in the media 
samples from the LDH time course experiment described in Section 4.5. Cultures (100 
μL) maintained for 13 DIV were subjected to compression injury (10 mm piston 
diameter, 500 mm/s velocity, 0.50 mm depth) or to sham injury. Medium was collected 
from injured cultures at 2, 4, and 8 hours (n=3 each) and from the sham cultures at 8 
hours (n=3). Medium was also collected at 8 hours from an uninjured LPS condition 
(n=2) as a positive control for IL-1β release. The ELISA data show that IL-1β release did 
not increase significantly with injury (Figure 5.4). The sham condition showed 
significantly higher IL-1β in the culture medium than the medium collected 2 hours post-
injury. However, since the sham medium was collected at 8 hours, this is not an 
equivalent comparison.  
5.4.2 Intracellular IL-1β protein expression 
 To determine if mechanical injury induced an upregulation in the intracellular 
protein expression of IL-1β, the cultures for which ELISA data were presented (Figure 
5.3) were processed for Western blot and probed for IL-1β. Confirmation of culture 
injury was determined by LDH assay (Figure 5.5A). The Western blot data illustrates that 






























Figure 5.3. Il-1β is not released at 4 hours in response to compression injury. Cultures 
(100 μL, 13 DIV) were subjected to compression injury (10 mm piston diameter, 500 
mm/s velocity, 0.50 mm depth) or to sham injury. Medium was collected at 4 hours (n=6 
for each condition). LPS (10 μg/mL) (n=2) was included as a positive control. IL-1β is 
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Figure 5.4. IL-1β release is not significantly increased over a time course after 
compression injury. Cultures (100 μL, 13 DIV) were subjected to compression injury (10 
mm piston diameter, 500 mm/s velocity, 0.50 mm depth) or to sham injury. Medium was 
collected at 2, 4, and 8 hours (n=3 each) and from the sham cultures at 8 hours (n=3). 
Medium was also collected at 8 hours from an uninjured LPS condition (n=2) as a 
positive control for IL-1β release. There is no time-dependent increase in IL-1β release 
due to compression injury and no significant difference from the sham condition. Data 





kD band) compared to the sham condition (Figure 5.5B). There appears to be a modest 
increase in band intensity with injury, but without a loading control, the densitometric 
data cannot confidently be statistically compared. The LPS positive control substantially 
upregulated immature IL-1β protein expression, and was the only condition for which the 
mature form of IL-1β (17 kD band) was detectable. 
 Immunocytochemistry provided visual confirmation of the Western blot data. 
Immunolabeling with anti-rat IL-1β antibody revealed only background signal in the 
naïve condition as well as in both the sham and injury conditions in the region adjacent to 
piston contact point (Figure 5.6A-C). In the LPS-stimulated cultures, positive IL-1β 
labeling was observed in cells with morphology consistent with microglia (Figure 5.6D). 
The background signal also appears in the LPS cultures and based on the pattern may be 
labeling fibrillar structures of astrocytes. The specificity of the labeling cannot be 
assessed as no pre-adsorption antibody controls were included. 
In order to confirm that the lack of IL-1β detection in response to injury was not 
simply attributable to the protein-level analysis, mRNA microarrays were used to 
compare injured and sham cultures. Two separate experiments on 150 μL flat cultures 
were carried out using two different piston sizes for compression injury. Microarray data 
comparing injured and uninjured cultures did not reveal any change in IL-1β at the 
mRNA level. Further, neither analysis showed transcriptional upregulation or 
downregulation of any gene of interest in response to mechanical injury despite the 

















Figure 5.5. Intracellular IL-1β is not significantly increased in response to compression 
injury. Cultures (100 μL, 13 DIV) were subjected to compression injury (10 mm piston 
diameter, 500 mm/s velocity, 0.50 mm depth) or to sham injury. (A) LDH activity in the 
medium at 4 hours indicated successful injury (p<0.0001). Cultures (n=6 for each 
condition) were collected, pooled (3 cultures pooled per sample, pooled n=2), degraded, 
and protein was extracted for Western blot. LPS (10 μg/mL) (n=2, pooled n=1) was 
included as a positive control. (B) Western blot data for the samples reveals a small 
increase in intracellular, immature IL-1β in response to compression injury. This 
difference cannot be statistically compared due to the lack of a loading control. LDH data 
for sham and injury conditions were statistically compared using a one-tailed, unpaired t-











Figure 5.6. Immunolabeling for IL-1β is not detectable in response to compression 
injury. Cultures (150μL, flat, 21 DIV) were subjected to compression injury (4 mm piston 
diameter, 500 mm/s velocity, 1.00 mm depth), to sham injury, to a naïve condition, or to 
LPS stimulation (10 μg/mL final concentration) (n=3 each). Fixed cultures were 
incubated with antibody against IL-1β. IL-1β labeling appears nonspecific and fibrillar 
for the naïve (A), sham (B), and injury (C) conditions. The LPS condition (D) shows 




5.5 Effect of in vitro compression injury on NO production 
 Due to the lack of success in inducing IL-1β release, NO production in response 
to mechanical injury was assessed. The availability of a NO-sensitive infrared dye 
allowed for near real-time monitoring of NO release post-injury, potentially capturing an 
acute injury response that was previously undetectable. Both sham and injury conditions 
had significantly higher fluorescence than the naïve condition (p<0.05) as is visually 
apparent in the raw data (Figure 5.7A) and in the quantification of the fluorescence 
(Figure 5.7B). Neither condition was significantly different from the LPS control, nor 
were they significantly different from each other. It is worth noting, however, that the 
pattern of fluorescence observed in the injury condition exhibits precisely the desired 
profile for this model of neuroinflammation. There is a halo of increased signal around 
the piston impact site which corresponds to an injury penumbra and umbra, respectively. 
These direct NO measurements were not corroborated by the levels of nitrite in the 
medium. The only condition that gave detectable signal was the LPS positive control 
(Figure 5.7C). Potential explanations for this discrepancy are addressed in Section 5.9. 
5.6 Effect of in vitro compression injury on ROS production 
 A time-dependent profile of superoxide production in response to injury was 
established using H-ICG, a superoxide-sensitive infrared dye followed by compression 
injury. At 20 minutes post-injury, the raw fluorescent signals from both injury conditions 
were noticeably higher than the sham condition (Figure 5.8A). Quantification of the data 
showed that both injury conditions exhibited significantly higher levels of fluorescence 
than the sham condition (p<0.001), but that they were not significantly different from 





Figure 5.7. NO production in response to compression injury. Cultures (150 μL, flat, 13DIV) were subjected to compression injury (4 
mm piston diameter, 500 mm/s velocity, 1.00 mm depth), to sham injury, to a naïve condition, or to LPS stimulation (10 μg/mL final 
concentration) (n=3 each). After 24 hours, the cultures exposed to a NO-sensitive hydrocyanine infrared dye (in DPBS) for 1 hour. 
The cultures were rinsed with DPBS and imaged using an IVIS Lumina® near-infrared imaging system. (A) Raw in situ NO dye 
fluorescence shows an increase in signal for both the sham and injury conditions relative to the naïve. (B) Quantification of this data 
confirms that these increases are statistically significant (p<0.05), but indicates that the injury condition is not significantly different 
from the sham. (C) Levels of nitrite in all but the LPS condition were undetectable. Data were statistically compared using one-way 






Figure 5.8. ROS production in response to compression injury. Cultures (100 μL, 8 DIV) were pre-exposed to H-ICG (250 μM in 
DPBS) for 1 hour. The cultures were then subjected to compression injury (10 mm piston diameter, 500 mm/s velocity) to a depth of 
either 0.75 mm or 1.00 mm or to sham injury (n=3 for each condition). Additionally, there was a set of cell-free Matrigel™-only 
controls (n=3) that were treated as a naïve condition would have been. DPBS was added to the cultures and they were imaged using an 
IVIS Lumina® system at time points up to 13 hours post-injury. (A) Raw in situ superoxide-sensitive dye fluorescence at 20 minutes 
post-injury shows an increase in signal for both injury conditions relative to the sham. (B) Quantification of this data confirms that 
these increases are statistically significant (p<0.001), but indicates that the injury conditions are not significantly different from each 
other. (C) Time course data shows that the signal for the sham and injury conditions continues to rise, while the cell-free control signal 
levels off. The injury and sham data remain significantly different through 5.5 hours. Data were statistically compared using one-way 




significantly different from that of the cell-free Matrigel™ control. The fluorescent signal 
of the injury and sham conditions continued to rise over time, while the cell-free signal 
leveled off (Figure 5.8C). The injury and sham data remained significantly different 
through 5.5 hours post-injury, but began to converge after this point. The 3.5 hour time 
point and time points beyond 7.5 hours were omitted due to falsely high readings given 
by auto-exposure issues with the IVIS Lumina® system. 
5.7 Effect of LPS pre-treatment on compression-injury induced inflammation 
 It was hypothesized that mechanical injury alone may not be sufficient to elicit 
the expected inflammatory response in the 3-D multitypic neural cultures. Cultures (100 
μL) maintained for 7 DIV were “primed” with medium containing LPS (10 μg/mL) for 2 
hours, rinsed, then subjected to compression injury (10 mm piston diameter, 500 mm/s 
velocity, 0.50 mm depth) (n=6) or to sham injury (n=3). Medium was collected from the 
cultures 4 hours later and levels of IL-1β were determined by ELISA. Significantly more 
IL-1β was released from the injured cultures compared to the sham cultures (p<0.0001) 
(Figure 5.9). This indicates that exposing the cultures with LPS or another pro-
inflammatory reagent prior to injury may be necessary to generate a detectable 
inflammatory response. 
 5.8 Effect of adding adult mouse microglia to the 3-D multitypic neural cell cultures 
 Given the apparent requirement of an additional stimulus to produce an 
inflammatory response to in vitro injury, it became clear that the 3-D multitypic neural 
cultures may not possess the necessary components to generate the expected response. To 
determine if the immaturity of the microglia was affecting the outcome, adult microglia 






























Figure 5.9. IL-1β release in response to compression injury requires LPS pre-treatment. 
Cultures (100 μL) maintained for 7 DIV were “primed” with medium containing LPS (10 
μg/mL) for 2 hours, rinsed, then subjected to compression injury (10 mm piston diameter, 
500 mm/s velocity, 0.50 mm depth) (n=6) or to sham injury (n=3). At 4 hours, levels IL-
1β are significantly increased in the medium of the injury condition compared to the 
sham (p<0.0001). Data were statistically compared using a one-tailed, unpaired t-test 




the adult microglia would exhibit the expected morphological or chemotactic behaviors 
that had not been observed with the postnatal rat microglia. Within a few days of adding 
the adult microglia to the 3-D multitypic neural cultures, they exhibited significant 
process extension. Compression injury induced neither a morphological shift nor a 
chemotactic response (not shown). However, 3 days of exposure to LPS resulted in 
concentration-dependent process retraction (Figure 5.10). 
5.9 Conclusions 
 This chapter has detailed the experiments designed to characterize mechanically-
induced inflammation of the 3-D multitypic neural cultures. In the absence of additional 
stimulation, the cultures failed to consistently produce a detectable response to 
compression injury using the chosen outcome measures. While the in situ detection of 
NO and superoxide using the near-infrared dyes sensitive to these species appeared 
promising, substantial variability was encountered in subsequent experiments. The source 
of these inconsistencies seemed to lie with the limitations of the IVIS Lumina® system 
which was designed for in vivo imaging. Often, the signal-to-noise ratio of the acquired 
infrared signal was fairly low, leaving a very small window in which acceptable data 
could be acquired. The result was that the subtle differences between the small cell 
populations in these cultures (compared to in vivo) were sometimes washed out by 
background signal or by nonspecific oxidation mechanisms of the dyes. Also concerning 
was the disagreement between the NO detected in the cultures and the levels of nitrite 
detected in the corresponding media samples (Figure 5.7). While this could possibly be 
attributed to normal interconversion pathways within the cells [185], it still casts doubt on 









Figure 5.10. Adult mouse microglia in the 3-D multitypic neural cell cultures exhibit a 
concentration-dependent morphological shift in response to LPS stimulation. GFP-
positive adult mouse microglia were added dropwise to cultures (7 DIV) and maintained 
for an additional 7 days. Live cells were imaged following 3 days of vehicle (A) or LPS 
treatment at final concentrations of 0.1 μg/mL (B), 1 μg/mL (C), or 10 μg/mL (D). Adult 
mouse microglia in vehicle-treated cultures exhibit process extension (A). The frequency 
of cells displaying a rounded morphology increases with increasing concentrations of 




 Most disappointing was the lack of detectable changes in IL-1β levels in response 
to injury. This cytokine was chosen as a likely marker for inflammation in this system 
partially based on the results of the LPS experiments presented in Chapter 2, but also 
because of the mechanism by which it released from cells. Release of IL-1β can occur in 
the acute phase following injury as it simply requires enzymatic cleavage to produce a 
mature protein from the pool of immature IL-1β present within the cell. Further, the 
known involvement of ATP signaling in this process made it an attractive candidate in a 
model where extensive membrane damage and cell death would be imparted. In response 
to compression injury alone, IL-1β was not released from the cell nor was its intracellular 
production upregulated at the protein or mRNA level. However, exposure of the cultures 
to LPS prior to compression or sham injury yielded a significant increase in IL-1β in the 
medium of the injured cultures. Although this is the desired outcome, this method of 
“priming” the cultures activates a different inflammation pathway than what would be 
expected in response to mechanical injury. Thus, from the standpoint of model 
development, it is not an ideal requirement. This once again calls into question the 
appropriateness of LPS as a positive control for this system, an issue that is addressed 
further in Chapter 6. Another concern is that although the sham cultures were exposed to 
LPS as well, the observed signal increase may have been the result of nonspecific IL-1β 
release due to direct damage to the cells rather than through a caspase-1-mediated 
pathway. 
 These concerns lead to the question of what this system is truly capable of 
modeling. In vitro systems are, by their very nature, far removed from their parent 




caveats. Assuming that functionality representative of an in vivo model has been 
demonstrated, as is the case here, the data can prove invaluable in the study of disease. 
The 3-D multitypic neural culture model combines three cell types in a novel way and 
has demonstrable potential for the induction of inflammation pathways. The inability to 
produce a reliable TBI-like inflammation response using the injury methods described 
here does not completely discount this as a model of neuroinflammation. There are 
numerous avenues in the design of the culture system (particularly matrix and medium 
composition) that, if modified, could result in a representative model. These possibilities 
are explored in more detail in Chapter 6 along with other possible applications for this 






6.1 Research summary 
 The research presented here was designed to investigate the potential of a 3-D 
culture system consisting of neurons, astrocytes, and microglia harvested from rat to 
serve as a model of mechanically-induced neuroinflammation. Iterative development of 
culture and plating methods ultimately yielded a 3-D multitypic neural culture with a 
high viability of the cell types of interest. Stimulation of these cultures with LPS 
produced the expected outcomes of: upregulation of the mRNA of various pro-
inflammatory cytokines, increased intracellular and extracellular levels of IL-1β protein, 
and increased NO production. Surprisingly, the inflammatory response did not trigger 
any cytotoxic mechanisms within the culture as there was no significant change in cell 
viability in response to LPS treatment. Also surprising was the lack of a shift in 
microglial morphology. Previously designed in vitro injury devices were adapted to suit a 
modular design for the 3-D culture chambers. Shear injury failed to induce cell death in 
the cultures and was abandoned as the mechanical injury model. Compression injury 
required an order of magnitude increase in the piston velocity to achieve the desired level 
of cell death in the 3-D cultures. However, when compared with sham conditions, this 
injury model failed to elicit increases in IL-1β protein expression, cytokine mRNA 
expression, and NO production. ROS production was significantly increased, but this 
result was inconsistent in subsequent experiments. When cultured were exposed to LPS 





6.2 Alternative culture conditions 
 Throughout the course of this research, variants of the previously described 
culture conditions and experimental parameters were implemented in attempts to elicit a 
mechanically-induced inflammation response. Some, such as the use of antioxidant-free 
B-27 supplement, became a part of the final culture protocol. Others had no effect but are 
discussed here to illustrate the many avenues pursued in the development of this culture 
system. 
6.2.1 Alternative 3-D hydrogels 
 Although Matrigel™ has long been used in our lab to promote high primary cell 
viability and the development of mature neural networks, it has disadvantages. Its 
composition is not very well-defined since it is generated from extracts from an in vivo 
host. In addition to the controlled ratios of laminin, collagen IV, and HSPG, there are a 
host of growth factors present, even in the formulation in which they have been reduced. 
While this is helpful in supporting cellular survival, it is certainly a downside in a system 
designed to model secondary injury processes. Aside from the presence of growth factors, 
laminin has been shown to have neuroprotective properties [186, 187], even in its 
polymerized form [188]. 
Some alternative hydrogels that were considered included: collagen I, silk fibroin, 
and self-assembling peptide nanofibers. Type I collagen has attractive mechanical 
properties for an injury model, but is not a normal component of the CNS ECM. 
Similarly, silk fibroin would be a good choice from a mechanical perspective, but not a 
biological one. Indeed, a combination of silk fibroin and collagen I has been used to 




nanofiber, RADA16 (commercially, BD PuraMatrix®), was implemented with primary 
neurons. Short peptides (~12-16 amino acids) with alternating acidic and basic side 
chains separated by hydrophobic residues will spontaneously form beta-sheet secondary 
protein structure upon addition of a medium containing dissolved salts. Multiple attempts 
were made to seed neurons in this gel, but the cells never extended processes and the gel 
itself rapidly degraded by layered delamination. It has been reported that the cells from 
the BV-2 microglia cell line extend processes in this scaffold [190]. 
Regarding some of the negative attributes of Matrigel™, it should be noted that 
two of the growth factors present in the formulation, EGF and bFGF, are also present in 
G-5 supplement at concentrations 4 and 6 orders of magnitude higher, respectively. 
Obviously, this does not negate the potential interference of the other growth factors with 
the hypothesized injury response, but it indicates that their concentrations may be 
negligible. In terms of the neuroprotective attributes of laminin, it has been reported that 
laminin is produced by astrocytes in primary cultures derived from embryonic and 
newborn rats [191], so even in the absence of Matrigel™ there would still be plenty of 
laminin present. Thus, growth factor-reduced Matrigel™ was settled upon as the scaffold 
for these investigations. 
6.2.2 Effects of ECM composition on microglial phenotype and activity 
 The key ECM proteins responsible for the appearance of function of microglia in 
culture appear to be fibronectin and laminin [192, 193]. Both proteins have been shown 
to increase in the penumbral region after CCI in mice [194]. 2-D preparations of 
prenatally-derived rat microglia extended processes on a fibronectin substrate but 




postnatally-derived mouse microglia grown on laminin also exhibited a weakly adhered, 
rounded phenotype, cells grown on fibronectin did as well [193, 195]. In contrast to these 
preparations, the microglia grown in the 3-D multitypic neural cultures extended 
processes despite laminin being the primary constituent of the hydrogel. Based on its 
implication in IL-1β release from microglia [196] and astrocytes [197] in primary rat 
cultures, the absence of fibronectin from the Matrigel™ formulation was thought to be 
contributing to the lack of detection of the IL-1β in response to injury. To determine if 
the presence of fibronectin in the ECM would affect IL-1β release, it was added to a 
Matrigel™ preparation prior to 3-D cell plating. This addition did not have any effect on 
secreted IL-1β levels 24 hours after compression injury when compared to standard 
preparations. However, based on the in vivo CCI data [194], the microglia may only 
respond to a fibronectin gradient in the region surrounding the injury rather than to its 
addition to the bulk ECM. 
6.2.3 Effects of medium supplements on microglial activity 
 Throughout the previous chapters, modifications to the medium used for the 3-D 
multitypic neural cultures have been discussed. In order to assure a healthy mix of 
neurons and glia without allowing the glia to overtake the cultures, G-5 supplement was 
included at the time of plating and at the two subsequent feedings at 90 minutes and 24 
hours. Thereafter, half-medium exchanges were with medium lacking G-5. As mentioned 
in Chapter 2, this delayed the onset of gel contraction from 1 week to at least 2 weeks 
after plating. However, in order to confirm that the removal of G-5 did not affect the 
potential for IL-1β release, a post-injury time course experiment was run on cultures that 




previously presented data collected in parallel from cultures maintained without G-5 (see 
Figure 5.4). Since there were also no observed effects on cellular health, the weaning 
protocol for G-5 was continued. 
 The clear decision to use antioxidant-free B-27 supplement in place of the 
baseline formulation was immediately beneficial in the fluorescence studies with the 
infrared ROS sensor dye. One of the included antioxidants was superoxide dismutase 
which completely abolished any signal that could have been detected using the dye. 
However, even in the modified formulation, B-27 contains a substantial amount of bovine 
serum albumin (enough to be visible to the naked eye on PVDF membrane after 
electrophoretic transfer for Western blot), which has been reported to have antioxidant 
properties [198]. Additionally, the supplement contains progesterone, which has been 
used in clinical trials for TBI treatment. Despite the presence of these species, elimination 
of B-27 supplement from the culture medium in the days preceding injury did not have an 
effect on microglial response to injury. 
6.3 ATP stimulation of cultures 
 Given the previously described involvement of ATP signaling in IL-1β release, as 
well as the demonstration of ATP-induced microglial chemotaxis both in vivo [65] and in 
vitro [132], it was logical to include ATP stimulation in parallel with the injury studies 
presented here. In lieu of the standard ATP molecule, the highly active BzATP form was 
used as it is a potent agonist of the P2X7 receptor, which is directly involved in IL-1β 






6.3.1 ATP as a positive control 
The integral roles played by ATP in microglial function would possibly make it a 
better candidate for a positive control than LPS. Additionally, the ideal model for in vitro 
injury using this culture system would involve the formation of ATP gradients from the 
umbral region of injury into the penumbral region where a microglial response would be 
induced. Whereas LPS was an acceptable positive control for the outcome measures 
utilized in this research, the mechanism by which it elicits IL-1β release is through the 
TLR4-mediated innate immune pathway, which it not physiologically relevant to a TBI 
model. ATP would certainly have been more meaningful from a biochemical signaling 
perspective. 
6.3.2 BzATP stimulation of 3-D multitypic neural cell cultures 
 BzATP was utilized in parallel with a limited number of experiments in an 
attempt to amplify the microglial response to mechanical injury. When delivered in 
combination with LPS, the combined treatment reduced the levels of IL-1β detected in 
the medium. This finding may correlate with the observed ATP-induced process 
retraction of LPS-stimulated microglia [132]. Combined LPS/BzATP treatment did not, 
however, result in a visible difference in intracellular IL-1β immunolabeling compared to 
LPS stimulation alone. Stimulation of cultures with BzATP after mechanical injury 
produced a modest, but not significant increase in immature IL-1β levels compared to the 
sham condition as determined by Western blot. However, there was no significant 
difference between this result and that obtained from the previously presented 
unstimulated cultures (see Figure 5.5). Finally, BzATP stimulation had no effect on NO 




not as physiologically relevant to the TBI inflammation mechanisms, LPS is a successful 
positive control due to the breadth of its effect on pro-inflammatory outcome measures. 
Stimulation with standard ATP may have produced different results since the BzATP 
molecule is specifically a P2X7 agonist. Additionally, bulk delivery in the medium may 
not have been the best course for exposure as there would be no gradients established. 
6.4 Future directions 
6.4.1 Injury model 
6.4.1.1 Model limitations 
 The research presented here indicated that aside from inconsistently detected 
superoxide release, mechanically-induced neuroinflammation in these cultures requires 
priming with LPS prior to injury. Mechanical injury alone, as delivered by piston 
compression, failed to produce the expected inflammatory response. In its current state, 
this system cannot be said to be an in vitro model of TBI-induced neuroinflammation as 
the only aspect of TBI that has been successfully and consistently represented is acute 
cell death directly induced by the injury mechanism. The design of the system may be 
inherently incapable of recapitulating the in vivo inflammation response simply because it 
is lacking too many of the peripheral physiological cues. The model lacks circulating 
macrophages and cells of the immune system that would be present in the event of a BBB 
breach. Possible incorporation of a pseudo-BBB into this culture system was discussed, 
but never successfully implemented. Potentially, a simulation of BBB breach could be 
achieved through the addition of blood or blood products to the culture immediately 




modifications that could be made to the system as it is to promote the induced 
inflammation response. 
Possible explanations as to why the expected microglial behavior was not 
observed or detected have been alluded to throughout this chapter. The complex effects 
that the ECM has on microglial differentiation and response points to a need to re-
evaluate the hydrogel chosen for this system. If the presence of laminin and growth 
factors is indeed behaving in a neuroprotective manner, then any inflammatory response 
occurring may be masked. Another consideration is the fact that the cells used in the 3-D 
multitypic neural cultures are sourced from prenatal and postnatal tissues. The immaturity 
of the cells may affect the expected response to injury. Finally, the two-phase nature of 
the 3-D culture system (cell-seeded scaffold and medium) may be preventing the 
formation of signaling gradients within the culture. The existence of an injury penumbra 
was visualized using the NO-sensitive dye (see Figure 5.7). However, the fact that 
released factors diffuse into the medium as well as through the gel creates a situation that 
is hardly different than if the factors (i.e. ATP) had been introduced to the culture through 
the medium. In this case, there would be no gradients to elicit the expected microglial 
response. Indeed, it has been demonstrated in vivo that exogenous ATP prevents 
microglial chemotaxis toward the site of injury, presumably due to the elimination of the 
local ATP gradient [65]. All of these factors should be taken into consideration before 
moving forward with this injury model. 
6.4.1.2 Future directions for modeling secondary injury processes in TBI  
 Taking into consideration the described limitations of the injury system, a number 




neuroinflammation. Implementing a more defined 3-D culture scaffold would be ideal; 
provided that the cells exhibited process extension and that the microglia exhibited 
process extension. To address the immaturity of the cultured cells, adult cells could be 
incorporated into the system. While this is not feasible for neurons as culturing 
dissociated adult neurons has been largely unsuccessful, the microglia and possibly the 
astrocytes could be considered. Incorporation of adult mouse microglia has already been 
demonstrated in these cultures (see Figure 5.10). It is possible that the method for 
harvesting these cells would translate to rat brain, but this has not been attempted. To 
address the lack of formation of signaling gradients, a number of approaches can be 
considered. At the simplest level, the addition of medium following injury could be 
eliminated. The scaffold is composed primarily of aqueous medium and should remain 
sufficiently hydrated in a humidified incubator for acute time point studies. For longer 
time points, evaporation could be prevented through the use of gas permeable FEP 
membrane to cover the culture wells [199]. Should this fail to elicit a response from the 
microglia, the cell density of the cultures could be increased. At 4,000 cells/mm3, the 3-D 
cultures are near the maximum density for which high (>90%) viability was sustained 
throughout culture. In order to increase the density, a system of continuous medium 
perfusion would likely need to be implemented to assure sufficient diffusion of oxygen 
and nutrients. Any or all of these modifications to the injury or culture method could 







6.4.2 Applications of the culture system 
 The culture system itself has a number of applications beyond its incorporation 
into the mechanical injury system. For example, given the immaturity of the cells, the 
system could potentially be used to model diseases of early development including fetal 
alcohol syndrome. The 3-D multitypic neural cultures have already been utilized for other 
purposes. The cultures were successfully incorporated into a novel in vitro 
microsampling device for mass spectrometry which is capable of continuous, spatially 
resolved detection of biomarkers [200]. The cultures were also used in an unpublished 
pilot study of in vitro blast injury. Modified cultures chambers were used in which a 
flexible silicone membrane rather than a rigid glass slide formed the surface of the wells. 
A blast wave was propagated, and the resulting reduction in cell viability was assessed. 
These same flexible-bottom culture chambers could also be implemented in another 
injury model that more closely resembles the 2-D membrane stretch method. The 3-D 
multitypic neural cultures would also be valuable for toxicity assessment, and should the 
inflammatory response be consistently potentiated, for assessment of materials designed 
for neural implantation.  
 The redesigned culture chamber for the generation of flat 3-D cultures described 
in Chapter 5 could be used in a variety of culture applications separate from neural tissue. 
The cultures could be created using Matrigel™ as described here or using a hydrogel more 
appropriate for the tissue type. The ability to reliably create a 3-D gel with uniform 
thickness has great potential for use in applications such as invasion assays. Further 
development of the chamber to include multiple concentric levels would allow for 




organization is relevant. In the realm of neuroscience research, neurons harvested from 
different brain regions could be cultured in separate layers or cell types could be spatially 
separated. Such versatility in recreating tissue-like spatial cellular arrangements in vitro is 
a major advantage of this custom-made culture chamber. 
6.5 Alternative approaches for studying microglia-driven neuroinflammation 
 The integration of the 3-D multitypic neural culture system into the compression 
injury model of TBI was performed with the goal of studying inflammation-based 
secondary injury mechanisms in vitro. The novel incorporation of microglia into a 3-D 
culture formerly consisting solely of neurons and astrocytes was meant to create a more 
complete representation of the complex signaling pathways associated with mechanical 
injury of neural tissue. This dissertation has detailed the iterative development of this 
culture model and its implementation in neuroinflammation studies. Attempts to induce 
an inflammatory response to mechanical deformation ultimately fell short in the absence 
of additional pro-inflammatory stimulation. Possible explanations for this based on 
system design have already been explored in this chapter. However, taking a step back 
and re-evaluating the manner in which the overall problem was addressed is merited. 
Through the lens of the knowledge gained through the characterization of the culture 
system, an exploration of alternative methods of studying the microglial response to TBI 
may point to better paths for future research. 
  The cellular composition of the 3-D cultures has already been discussed as a 
target of system modification in the context of incorporating adult, rather than perinatal 
microglia. Also discussed was the possibility of introducing blood or blood products to 




Since LPS priming prior to mechanical injury was demonstrated as a successful method 
for inducing IL-1β release, an alternative 3-D model to that presented here could consist 
of cells acquired from animals that have already been exposed to a pro-inflammatory 
challenge. Specifically, prior to P0 glial harvest, pregnant dams could be subjected to 
LPS injection to initiate inflammatory cascades in the developing embryos. By pre-
conditioning the animals in this manner, the inflammatory response of the intact animals 
would serve to prime the cells intended for culture. Subjecting cultures consisting of cells 
harvested from these or control-injected animals to mechanical injury may reveal a 
differential response based on pre-harvest treatment. Pre-conditioning with LPS or with 
other treatments such as hypoxia or possibly even in utero TBI could result in a 3-D 
culture model of neuroinflammation that is responsive to mechanical injury.  
Along the same lines, microglia from adult injured and uninjured rats could be 
incorporated into 3-D cultures of neurons to study the mechanisms by which the injury-
activated microglia interact with the healthy neurons. Again, the use of cells from 
animals exposed to insult would address the issue of the absence of peripheral interaction 
in the current model and thus improve its physiological relevance. This would effectively 
combine the advantages of a well-characterized in vivo injury (such as CCI) with the 
control and ease of manipulation of an in vitro model. Since this method would eliminate 
the need to mechanically injure cultures, studies could also be conducted using 2-D 
cultures. Setting aside for a moment the advantages of 3-D culture, a major simplification 
to the system could be a reversion to 2-D cultures. The aforementioned pre-conditioned 
cell experiments could provide insight into the microglial response to TBI in 2-D as the 




Additionally, in vitro stretch injury experiments could be performed on cultures 
consisting of neurons and astrocytes to which microglia from either normal or injury-
conditioned animals could later be added. 
The disadvantages of dissociated cell culture could be avoided by studying 
microglia-driven neuroinflammation using slice cultures. Organotypic slice cultures from 
rat cortex, hippocampus, or other brain regions could be cultured in such a way that they 
would be compatible with the CCD described here. The retention of the neuroanatomy in 
this ex vivo preparation would address the issues of cell density and signaling gradient 
formation characteristic of the dissociated 3-D cultures. The experimental design would 
be along the same lines as the research presented here. Slice cultures would be exposed to 
compression injuries of various severities and the resulting inflammatory response could 
be measured using the same outcome measures as those used for the 3-D multitypic 
neural cultures. Should a response not be detected using these methods, the previously 
discussed addition of microglia derived from a pre-conditioned animal could be 
implemented. Alternatively, the in vitro injury could be eliminated and slices from 
injured and uninjured animals could be cultured and studied directly. 
Each of these alternatives to the system described here has inherent advantages 
and disadvantages. While slice cultures have the distinct advantage of preserving the 
tissue architecture, sufficient nutrient delivery to prevent culture degradation is a constant 
concern. 2-D cultures have the benefits of ease and convenience, but they limit both the 
culture density and complex cell-matrix interactions. The culture of cells derived from 
animals pre-conditioned with LPS, hypoxia, or injury would address some of the 




going to the trouble of culturing those cells, the proposed experiments should be carried 
out in vivo.  
The novelty of the 3-D multitypic neural cell culture model is its integration of the 
three cell types most directly affected by TBI. Neurons are the most vulnerable 
population to mechanical deformation. Astrocytes are vulnerable as well, but typically 
have a higher survival rate and are an integral part of the post-injury response. Microglia 
as the immune effectors of the CNS, are a required component for recreating post-injury 
inflammation in vitro. The goal of this research was to create a model of injury-induced 
neuroinflammation. The reasoning behind using healthy tissue as the cell source for the 
3-D cultures was to make the in vitro injury the sole source of insult so that the complete 
injury response could be captured. While this may have been altruistic, the research 
presented here describes a system that nearly achieves this goal. Implementation of some 
of the proposed culture modifications could push this system further toward reaching that 
goal. However, if this research were to be undertaken again informed by the data gleaned 
from the experiments described here, one or more of the alternative approaches described 
would be carried out in parallel with the studies using the 3-D multitypic neural cultures. 
Preparations of slice cultures, 2-D cultures, or alternatively sourced 3-D cultures would 
allow for critical comparison with this in vitro model. Additionally, parallel in vivo injury 
studies would provide a benchmark for the expected inflammatory response to TBI. 
Admittedly, much of this research was focused on attempting to elicit a response from the 
3-D culture system that may not be feasible. Comparison studies would have possibly 
indicated the shortcomings of the culture system earlier and facilitated optimization to 





 The research presented in this dissertation demonstrated the development of a 
novel 3-D multitypic neural culture system in which rodent neurons, astrocytes, and 
microglia were maintained with high viability for weeks in vitro. The cultures, and 
specifically the microglia within them, responded to LPS stimulation with the expected 
elevation of key markers of neuroinflammation. A unique culture chamber was devised 
that permits the generation of 3-D cultures with a uniform geometry. A mechanical 
compression injury system was modified and successfully imparted a focused insult to 
the 3-D cultures. The hypothesized microglial secondary injury responses to the 
mechanical injury were not observed consistently enough to claim support for the 
hypothesis. However, implemented manipulations of the system such as LPS priming 
ultimately showed positive results. Further, proposed manipulations to promote gradient 
development are believed to be an avenue by which the model may be validated without 
the need for pre-stimulation. Overall, these investigations have successfully yielded a 
novel 3-D culture environment with numerous potential applications both within the area 





3-D MULTITYPIC NEURAL CELL CULTURE METHODS 
A.1 Generation of 3-D multitypic neural cell cultures 
**Any pipetting step of or into Matrigel™ should be performed using ice-cold pipet 
tips.** 
 
A.1.1 Preparation for 3-D culture 
 
A.1.1.1 Stock Matrigel™ preparation 
 
• 10 mL vial arrives on dry ice 
• Thaw on ice in the refrigerator overnight (will be very viscous, but free-flowing) 
• Dilute to 15 mg/mL with ice-cold HBSS; swirl to mix 
• Aliquot (2.0 mL) into cold 50 mL conical tubes and store at -20°C 
(NOTE: When preparing aliquots, draw up and expel Matrigel one time before 
transferring to coat the inside of the tip.  Otherwise, the delivered volume will be 
low.) 
 
A.1.1.2 Culture preparation (day before plating) 
 
• Thaw aliquot(s) of Matrigel™ on ice in the refrigerator overnight 
• Pre-coat sterile culture vessels (culture wells, glass coverslips, etc) with 100 
μg/mL (in sterile, de-ionized water) poly-D-lysine overnight at 37°C.  
 
A.1.1.3 Acquisition of cells 
 
• All animals are from Charles River Laboratories and arrive on Tuesdays 
• Embryonic day 19 (E19) dams are ordered for glial cells; harvest on day litter is 
born (postnatal day 0 (P0) which is usually on E22) (Friday) 
• Embryonic day 16 (E16) dams are ordered for neurons; harvest on E18 (13 days 
after E19 harvest) (Thursday) 
• Acquire glial cells from P0 tissue as described in "P0 cortical dissociation" 
protocol (below) 
• 13 days after plating glial cells, perform harvest of brains from E18 rat embryos 










A.1.2 3-D plating 
 
• Rinse coated culture vessels twice with sterile, de-ionized water 
• Aspirate second rinse thoroughly and allow vessels to dry in hood while preparing 
cultures 
• Perform dissociation of E18 cortices as described in Section A.1.4 
• Agitate a T75 flask of mixed glial cells generated as described in Section A.1.3  
• Remove and reserve medium in a 50mL conical tube 
• Rinse with 10 mL of PBS 
• Add 3 mL of room temperature trypsin-EDTA and incubate at 37 °C for 5 
minutes or until cells have loosened from flask surface 
• Add 7 mL of reserved medium to the flask 
• Using a 10 mL serological pipet, transfer cells from the flask to the conical tube, 
making sure to use the cell suspension to rinse the surface of the flask to 
maximize yield 
• Centrifuge at 200 rcf for 5 min 
• Remove supernatant and resuspend pellet with 2 mL of 3-D multitypic culture 
plating medium 
• Dilute 10 µL of cell suspension in 190 µL HBSS and count using hemacytometer 
(microglia will stick to surface, include these in total count; typically, they 
comprise ~15% of the total cells present in the suspension, but this is just an 
estimate and is quite variable) 
• Count neurons from E18 dissociation as described in Section A.1.4 
• The ultimate desired concentration of all cells in the 3-D culture is 4,000 cells/µL 
(4x106 cells/mL) 
• For a 2:1 ratio of neurons to glia, dilute neurons to 10.67x106 cells/mL and dilute 
glia to 5.33x106 cells/mL 
• For a 1:1 ratio of neurons to glia, dilute both suspensions to 8x106 cells/mL 
• To a 2.0 mL aliquot of Matrigel™, add 1mL of each cell suspension using ice-cold 
pipet tips 
• Swirl tube to mix 
• Using ice-cold pipet tips, gently plate the 3-D cultures using in a circular fashion, 
using the tip to guide the formation of the layer of gel (200 µL in a 2 cm2 culture 
well will produce a ~1mm thick culture) 
• Gently transfer cultures to incubator and allow to incubate for 90 min 
• Gently add warmed culture medium to the cultures (250 µL per cm2 of culture 
surface) 
• Feed cultures by replacing half of the medium after 24 hours 
• Feed every 2-3 days thereafter using Neuronal medium (without G-5 supplement) 









A.1.3 P0 cortical dissociation (mixed glia) 
 
• Dissect cortices from brains of P0-P1 rat pups (2 whole brains/4 hemi-cortices per 
T75 flask) in cold HBSS (or L-15 which seems to lead to a dissociation with 
fewer clumps) 
• Mince the cortices into 1-2 mm chunks using dissecting knives 
• Transfer tissue to a 15 mL (if plating one flask) or 50 mL conical tube and carry 
out dissociation in laminar flow hood 
• Remove supernatant HBSS 
• Add 3.6 mL room temperature trypsin  
• Swirl to mix and place tube into water bath for 20 minutes; agitate periodically 
(~every 5 min)  
• Add 400 μL DNase and swirl to mix 
• Add 4 mL of Glial medium 
• Mix gently with 5 mL serological pipet to begin breaking up tissue 
• Triturate with 5 mL serological pipet 
• Mix gently with flame-narrowed Pasteur pipet 
• Triturate with flame-narrowed Pasteur pipet 
• Allow any remaining clumps of tissue to settle and remove using Pasteur pipet 
• Centrifuge at 200 rcf for 5 min 
• Remove supernatant 
• Resuspend with 8 mL of medium 
• Mix gently and triturate with 5 mL serological pipet  
• Mix gently and triturate with flame-narrowed Pasteur pipet 
• Allow any clumps to settle and remove using Pasteur pipet 
• Dilute with medium up to appropriate volume (final volume is 10 mL for every 
T75 flask) 
• Plate into T75 flask(s) 
• Replace medium after 3 days and every 2-3 days for one week 



















A.1.4 E18 cortical dissociation (neurons) 
 
• 13 days after plating glial cells, perform harvest of brains from E18 rat embryos 
• Dissect cortices from brains in cold HBSS (or L-15 which seems to lead to a 
dissociation with fewer clumps) 
• Transfer tissue to a 15 mL conical tube and carry out dissociation in laminar flow 
hood or store in 2 mL of L-15 + B-27 supplement at 4°C for up to 24 hours. 
• Rinse 2X with cold HBSS 
• Add 5 mL room temperature trypsin 
• Swirl to mix and place tube into water bath for 11 minutes; swirl every 3 minutes  
• Rinse 3X with cold HBSS 
• Add cold HBSS up to ~3.6mL 
• Add 400 μL DNase swirl to mix at room temperature or warming gently in hands 
for 1-2 minutes until the cortices begin to separate from each other 
• Mix gently with 10 mL serological pipet to begin breaking up tissue 
• Mix gently and triturate with a 5 mL serological pipet 
• Mix gently and triturate with flame-narrowed Pasteur pipet 
• Allow any remaining clumps of tissue to settle and remove using Pasteur pipet 
• Centrifuge at 200 rcf for 5 min 
• Remove supernatant 
• Resuspend with 2 mL of 3-D multitypic culture plating medium 
• Mix and triturate with 2 mL serological pipet  
• Mix and triturate with flame-narrowed Pasteur pipet 
• Allow any clumps to settle and remove using Pasteur pipet 
• Dilute 10 μL of cell suspension into 190 μL HBSS; vortex to mix 
• Add 200 μL of trypan blue to diluted cells; vortex to mix 
• Count cells using hemacytometer 
• Determine viability (90% and higher is acceptable) and viable yield (should be 3-
5 x 106 cells per cortical hemisphere) 



















A.1.5 Media formulations 
 
Glial medium 
• 50 mL fetal bovine serum 
• 450 mL DMEM/F12 
 
Neuronal medium (also 3-D multitypic culture maintenance medium) 
• 2 mL B-27 supplement 
• 250 µL GlutaMAX 
• Dilute to 100 mL with Neurobasal medium 
 
3-D multitypic culture plating medium 
• 2 mL B-27 supplement 
• 1 mL G-5 supplement 
• 250 µL GlutaMAX 
• Dilute to 100 mL with Neurobasal medium 
 
*For inflammation studies, B-27 (Minus AO) and Neurobasal medium without phenol 
red are used. 
 
Table A.1. List of reagents used in 3-D culture preparation 
Name Company (Catalog Number) Stock Concentration 
Poly-D-lysine  
(MW >300,000) Sigma-Aldrich (P7405) 
100 µg/mL in sterile, de-
ionized H2O 
DNase Sigma-Aldrich (DN25) 
1.5 mg/mL in HBSS 







Dilute to 15 mg/mL with 
ice-cold HBSS 
Trypsin-EDTA 0.25% Invitrogen (25200-056) 0.25% 
DMEM/F12 Invitrogen (10565-018) n/a 




Neurobasal Medium Invitrogen (21103-049) n/a 
Neurobasal Medium (minus 
phenol red) Invitrogen (12348-017) n/a 
L-15 Medium Invitrogen (11415-064) n/a 
B-27 Supplement Invitrogen (17504-044) 50X stock 
B-27 Supplement Minus 
AO 
(w/o antioxidants) 
Invitrogen (10889-038) 50X stock 
G-5 Supplement Invitrogen (17503-012) 100X stock 




A.1.6 Example 3-D culture calendar 
 
 
Sunday Monday Tuesday Wednesday Thursday Friday Saturday 





   
DISSECTION 











































































A.2 Preparation of custom-made culture chambers for 3-D plating 
• Clean culture chamber slides: 
o Rinse with tap water and remove any large debris remaining in chamber 
o Soak in tap water with Alconox for 30 min. to overnight 
o Soak in de-ionized water for 10 min. 
o Soak in 70% ethanol for 10 min. 
o Soak in acetone for 10 min. 
o Use a cotton swab to wipe the inside of each culture well  
o Soak in 70% ethanol for 10 min. 
o Soak in de-ionized water for 10 min. 
• Transfer culture chamber slides to an autoclavable container or bag 
• Seal and autoclave 
• In a laminar flow hood, transfer chamber slides to culture dish(es) 
• Once completely cooled, add 0.5 mL of Poly-D-lysine (100 μg/mL in water) to 
each well and place in an incubator at least overnight and preferably 2X overnight 
(the hydrophilicity of the glass surface improves with repeated use in culture) 
• Rinse wells twice with 0.5 mL sterile, de-ionized water and allow to dry prior to 


















A.3 Manufacture and preparation of shear injury chambers 
 The previous injury chamber system was designed such that the frame and lid 
were machined from polycarbonate plastic.  PDMS culture chambers were glued to 
coverslips which were, in turn glued to the bottom of the plastic frame.  The current 
model can be used with PDMS chambers mounted to slides or coverslips (although slides 
are much easier to use).  Cells are grown in the culture chambers by themselves which is 
advantageous as they are readily sterilized by autoclaving.  For injuries, the culture 
chambers can be inserted into the rapid prototyped (Fullcure 720 material) injury 
chamber, injured, and then returned to the incubator.  The same injury chamber can be 
used for all of the culture chambers. 
 
A.3.1 PDMS/glass culture chamber construction 
• Cast 3-well PDMS chamber in mold 
o Weigh out an appropriate amount of Sylgard 184 bulk polymer (~10 g per 
chamber) 
o Add catalyst (10:1 bulk polymer:catalyst ratio w/w) 
o Mix well by stirring with a plastic transfer pipet 
o De-gas to remove bubbles 
o Cast PDMS into mold made of wax or other material that does not inhibit 
PDMS curing 
o Use a syringe needle to pop any bubbles 
o Cure on a level surface 2X overnight at RT, remove from mold and place 
in 70-80 °C oven for 1 hour 
 
• Adhere chamber to glass slide or coverslip 
o Slides should be 25mm x 75mm and 1mm thick (VWR plain: 48300-025) 
o Clean slide with ethanol and/or acetone 
o Insert slide into injury chamber frame and mark rectangular outline 
corresponding to PDMS mold using permanent marker 
o Remove slide and set on a flat surface, with the marked side down 
o Apply a thin layer of Dow Corning 734 flowable sealant to the smooth 
side (the side which was exposed to air) of the PDMS chamber and allow 
the sealant to self-level briefly 
o Press the PDMS chamber onto the slide within the outlined area 
o Allow to set overnight at room temperature 
 
• Permanent marker can be wiped off using ethanol 
• Use X-Acto knives to remove excess sealant from edges of PDMS wells (inside 
and outside) 









A.3.2 Shear injury chamber construction 
• All parts of the injury chamber are printed from CAD files on an Objet Eden 250 
printer using Fullcure 720 material.  The parts consist of: 
o A frame into which the culture chamber slide can be inserted 
o An insert which is placed in the frame after the chamber slide is in place 
to prevent movement of the slide assembly along the injury axis 
o A lid which has ‘C’-shaped feet into which PDMS inserts are adhered 
(Dow Corning 734 flowable sealant) such that when placed on top of the 
frame the PDMS makes gentle contact with the 3D culture 
o A bracket which attaches to actuator arm of the injury device on one side 
and to the injury chamber lid on the other side 
• Clean printed parts using a water jet 
• Soak the parts in a solution of 2% NaOH in water for 1-2 hours at room 
temperature.  This removes excess support material and induces uncured 
monomer to leach out of the part. 
• Rinse the parts with tap water and clean using a water jet 
 
A.3.3 Compression injury device construction 
• All parts of the injury chamber are printed from CAD files on an Objet Eden 250 
printer using Fullcure 720 material.  The parts consist of: 
o A frame into which the culture chamber slide can be inserted 
o Pistons of various diameters with 1 mm PDMS pads 
• Clean printed parts using a water jet 
• Soak the parts in a solution of 2% NaOH in water for 1-2 hours at room 
temperature.  This removes excess support material and induces uncured 
monomer to leach out of the part. 
• Rinse the parts with tap water and clean using a water jet 
 
A.3.4 Injury preparation (shear injury chamber) 
• Rinse the frame and lid to be used in the injury device with de-ionized water 
• Spray them with 70% ethanol, pat the outside dry and place into 15cm culture 
dishes in a laminar flow hood 
• Expose to UV light for 2+ hours 
• Transfer culture chambers to injury chamber using sterile technique in a laminar 
flow hood 
• Between injuries, wipe the PDMS feet on the lid with a Kimwipe dampened with 
70% ethanol and then perform a rolling dip into sterile medium in a 150 mm dish 
 
A.3.5 Injury preparation (compression injury device) 
• Clean piston and frame with 70% ethanol 







A.4 Immunocytochemistry for 3-D cultures 
• Remove medium 
A.4.1 Culture sectioning 
• Fix cultures with 2% paraformaldehyde in phosphate buffer for 30 min at RT 
• Rinse 5X with PBS 
• Cryoprotect cultures with 30% sucrose in PBS at 4°C overnight 
• Freeze cultures in OCT™ using isopentane and liquid nitrogen 
• Cut 30 µm sections using cryostat and mount on gelatin-coated slides 
• Store at -20°C until ready to perform immunocytochemistry (or -80°C for long-
term) 
• When ready to use for immunohistochemistry: 
o Allow slides to come to room temperature 
o Draw boundaries around culture slices using a hydrophobic pen 
 
A.4.2 Immunocytochemistry protocol (sectioned or intact cultures) 
 
• Block - 0.1% Triton X-100; 10% Horse Serum (HS); 0.05% saponin in PBS for 1 
hour at RT 
• Rinse 2X with PBS + 0.05% saponin (PBSS) 
• Primary - Incubate with antibody diluted in 1% HS in PBSS overnight at 4°C 
• Rinse 5X with PBSS 
• Secondary - Incubate with Donkey anti-primary species antibody (1:200 of 1:1 
glycerol-diluted stock, Jackson) in 1% HS in PBSS for 2 hours at RT 
• Rinse 2X with PBSS; 1X with PBSS + Hoechst 33342 (1:1,000); 2X with PBSS 
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